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Abstract
Some pharmaceutical company sales representatives are using bribes to encourage
increasing prescribing medication. GlaxoSmithKline paid $31 billion on a felony charge
related to bribing doctors to prescribe the company’s medications. Using Hunt and
Vitell’s general theory of marketing ethics, the purpose of this qualitative multiple case
study was to explore strategies some sales managers in the pharmaceutical industry used
to improve marketing training to reduce unethical sales representative behavior. Data
were collected from the company’s reports and documents provided by sales managers
and semistructured interviews with 5 sales managers of different pharmaceutical
companies in the northeast region of the United States. Data were analyzed using
thematic analysis and Yin’s 5-step process of compiling, disassembling, reassembling,
interpreting, and concluding data analysis. Three themes emerged from data analysis:
developing ethical standards, developing organizational policy, and implementing
training and development programs. A key recommendation is that pharmaceutical sales
managers identify ethical standards to inculcate in their business practices to achieve
ethical marketing training that can result in sales representatives’ ethical behavior. The
implications for positive social change include the potential for sales managers to develop
strategies to reduce unethical behavior in the pharmaceutical industry. Reducing
unethical behavior may lead to more trust between patients and physicians, improving
patient satisfaction, and promoting prosperity for the community through enhancing the
quality of health care.
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Section 1: Foundation of the Study
The occurring unethical sales representative behavior is a phenomenon that
destroy the credibility and reliability of the pharmaceutical industry (Munoz & Mallin,
2019). Some of the pharmaceutical company sales’ representatives use bribes while
marketing medications to doctors to encourage increasing prescribing medication
(Peltier-Rivest, 2017). In this study, I explored unethical sales representative behavior in
the pharmaceutical industry to identify strategies that sales managers could use to reduce
unethical sales representative behavior.
Background of the Problem
Marketing strategies are important to the pharmaceutical companies because there
is a positive correlation between marketing strategies and business performance
(Cacciolatti & Lee, 2016). Marketing strategies in the pharmaceutical industry include
marketing the products through the deployment of sales representatives (Shaw &
Whitney, 2016). The sales managers, in the pharmaceutical industry, provide essential
and extensive training to ensure following all measures for selling the products to the
physicians, clinics, or hospitals but unethical situations occur in the field (Khazzaka,
2019). The sales managers provide ethical considerations to sales representatives when
performing their practice but their strategies tend to become unethical due to illegal
transactions and relations with the physicians, hospitals, or clinics (Ameer & Halinen,
2019; Badrinarayanan et al., 2019a; Sasirekha, 2018). Therefore, it is imperative to
conduct an empirical research to determine the actions and strategies done by sales
managers in addressing the concerns shown by their sales representatives.
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Problem Statement
Pharmaceutical company sales’ representatives are marketing medications to
doctors, and some are using bribes to encourage increasing prescribing medication
(Peltier-Rivest, 2017). GlaxoSmithKline paid $31 billion in 2012 on a felony charge
related to bribing doctors to prescribe the company’s medications (Schipani et al., 2016).
The general business problem that I addressed in this study was that unethical behavior of
pharmaceutical company sales’ representatives results in financial losses for the
companies in the pharmaceutical industry. The specific business problem that I addressed
in this study was that some sales managers in the pharmaceutical industry lack strategies
to improve marketing training to reduce unethical sales representative behavior.
Purpose Statement
The purpose of this qualitative multiple case study was to explore strategies that
some sales managers in the pharmaceutical industry use to improve marketing training to
reduce unethical sales representative behavior. The targeted population consisted of five
sales managers located in the northeast region of the United States from three
pharmaceutical companies who have successfully used marketing training strategies to
reduce unethical sales representative behavior. The implications for positive social
change include the potential to develop strategies to reduce unethical behavior in the
pharmaceutical industry, which in turn may lead to more trust between patients and their
physicians, improving patient satisfaction, and promotion of prosperity for the
community through enhancing the quality of health care.
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Nature of the Study
Yin (2018) mentioned three types of research methods (qualitative, quantitative,
and mixed). Researchers performing qualitative research can accumulate a significant
amount of data and derive themes from the responses of individuals participating in the
research (Atchan et al., 2016). The qualitative research method was an appropriate
research method for this study because I collected data from multiple participants and
derived themes from the responses. The quantitative research method is suitable when
researchers want to examine variables’ characteristics or the relationship among variables
by testing hypotheses (Magruk, 2015). Therefore, a quantitative research method was not
appropriate for this study because I did not study variables’ characteristics or the
relationship among variables. Mixed methods research includes both qualitative and
quantitative methods (Archibald, 2016; Syed & Nelson, 2015). The mixed research
method was not appropriate for this study because I collected qualitative data from the
interview narratives to analyze and answer the research question, the use of quantitative
data was only for verifying the actual success of the strategies and identifying the
principal themes.
There are four principal designs for qualitative research: case study,
phenomenological, narrative, and ethnography (Yin, 2018). Researchers use a case study
design to describe a case in depth and within its real-world context (Lewis, 2015; Ridder,
2017). I used a multiple case study design because I explored several cases (not only one
case) in depth within their real-world environments to enable inter case comparison of
findings. Researchers use a phenomenological study design to describe the emotional and
personal experience of the participants with phenomena (Letourneau, 2015).
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Phenomenological design was not appropriate for my study because I did not describe the
personal meanings of the participants’ lived experiences. Using a narrative study design
involves collecting life stories from study participants that results in a shared narrative
context (Shapiro, 2016). I did not collect and explore life stories, so a narrative design
was inappropriate for this study. Qualitative researchers use an ethnographic design to
focus on a cultural exploration of the research topic (Baskerville & Myers, 2015). The
ethnographic design was not appropriate for this study because I did not focus on
exploring cultures.
Qualitative Research Question
What strategies do sales managers in the northeast United States use to improve
marketing training for their pharmaceutical company representatives to reduce unethical
behavior?
Interview Questions
1. What training strategies do you use to improve marketing training to reduce
unethical sales representative behavior?
2. What framework(s) did you use to develop and implement your ethical marketing
training program?
3. How did you assess the effectiveness of your strategies for marketing training?
4. What were the key challenges to implementing your strategies for ethical
marketing training elements?
5. How did you overcome the key challenges in the implementation of ethical
marketing training elements?
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6. What additional information would you like to share that we did not cover during
this interview about the strategies to improve marketing training used to reduce
unethical sales representative behavior?
Conceptual Framework
For the conceptual framework of this study, I used the general theory of
marketing ethics. In 1986, Hunt and Vitell (1986) developed the general theory of
marketing ethics, and they explained decision-making processes that marketing managers
employed to resolve ethical conflicts. Hunt and Vitell used a combination of utilitarian
(intentional) and deontological (judgmental) assessments through their theory to create
ethical marketing strategies. Utilitarian assessment means the action is right if its
outcomes (consequences) have benefits to most others, whereas deontological assessment
means looking at the morality of action itself based on rules rather than based on the
consequences of that action (Hunt & Vitell, 1986).
According to Gürçay and Baron (2017), individuals use the utilitarian system to
predict and discuss the consequences of an action. According to Gürçay and Baron,
individuals use the deontological system to focus on an emotional impulse when
responding to personal issues. Mayo and Marks (1990) used the general theory of
marketing ethics and explored how marketing managers handled an ethical marketing
problem. Generally, researchers have supported Hunt and Vitell’s (1986) model after
determining that combining of utilitarian and deontological assessments helps in
determining the ethical judgments to resolve dilemmas (Jurković et al., 2018; Mayo &
Marks, 1990). Individuals rely on utilitarian (intentional) or deontological (judgmental)
factors in forming their ethical response to an action (Gawronski & Beer, 2017).
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Therefore, the general theory of marketing ethics (including utilitarian and deontological
factors or assessments) was an appropriate lens through which to explore strategies to
improve marketing training for ethical marketing to reduce unethical behavior of sales
representatives in the pharmaceutical industry.
Operational Definitions
Epoché: Epoché-reduction is a phenomenon of reducing bias during research
through suspension of judgment (Van Manen, 2017). While conducting investigation,
researchers avoid their preconceptions and personal beliefs to avoid bias (Van Manen,
2017).
Deontological assessment: Deontological assessment means to assess the action
based on judgement (by looking at the morality of action itself based on rules rather than
based on the consequences of that action; Hunt & Vitell, 1986).
Teleological assessment: Teleological assessment means to assess the action
based on the intention, so the action is right if its outcomes have benefits to the majority
of others (Hunt & Vitell, 1986).
Assumptions, Limitations, and Delimitations
Assumptions
The researchers defined assumptions as nonrealistic situations that are used as
support in case there is no empirical evidence (Marshall & Rossman, 2016). The
researchers use assumptions as conditions to justify the validity of results (Lindebaum et
al., 2017; Preshaw et al., 2016). One of the assumptions in this study was that participants
accurately remembered their experience dealing with ethical marketing situations to
develop findings that reflect the real-life ethical marketing practice. Another assumption
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was the ability to capture the required data through the semistructured phone interview
and so that themes emerged. Additionally, I assumed that my personal beliefs and
experience did not interfere with the data collection process and presentation of the study
findings.
Limitations
Marshall and Rossman (2016) described research limitations as study weaknesses
or boundaries associated with conducting the study. Inability to generalize the study
findings was one of this study’s limitations. The limited number of participants (five sales
managers) from a limited number of organizations (three pharmaceutical companies)
located in a specific location (the northeast region of the United States) did not reflect the
views of all sales managers in the pharmaceutical industry. Transferability of the findings
to another industry was another limitation of this study because the focus was in
pharmaceutical industry. A further limitation was the level of participants’ honesty and
accuracy while responding to my interview questions. Potential participants may mention
that they have ethical behavior when they do not. Having dishonest or inaccurate
information from participants would have resulted in including participants that they
should not be included in this study.
Delimitations
The researchers defined research delimitations as the ability to control the
research scope by identifying the research boundaries (e.g., population, geographical
area, and sampling) (Marshall & Rossman, 2016; Yin, 2018). The population, in this
study, consisted of five sales managers located in the northeast region of the United
States from three pharmaceutical companies. Using a purposeful sampling method was
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another delimitation because the focus was on identifying sales manager (who have
successfully used marketing training strategies to reduce unethical sales representative
behavior) to provide truthful answers to the interview questions. A further delimitation
was focusing the scope of this research on exploring strategies that some sales managers
in the pharmaceutical industry use to improve marketing training to reduce unethical
sales representative behavior; therefore, not tackling other critical matters (e.g.,
profitability) that might affect leaders at the organizations. In addition, asking the
participants if they have successfully improved marketing training to reduce unethical
sales representative behavior was a delimitation.
Significance of the Study
Sales managers have the responsibility of maintaining ethical standards while
marketing the company’s products to buyers. Therefore, it is critical for sales managers,
in the pharmaceutical industry, to improve training to reduce unethical behavior of sale
representatives. Findings from this study may be of value to different sales managers at
pharmaceutical companies wishing to reduce the unethical behavior of sale
representatives. In the following headings, I will discuss the study’s potential
contributions to business practice and the implications for positive social change.
Contribution to Business Practice
Unethical behavior among pharmaceutical sales representatives is one of the
leading causes for corruption and financial fraud in the pharmaceutical industry (Villalba,
2019). Managers in the pharmaceutical industry must address unethical behavior because
ethics plays a crucial role in determining the performance of any business entity (Aziz et
al., 2016). Pharmaceutical sales managers may use the results of this study to develop
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effective marketing training strategies to reduce unethical behavior of sales
representative, which in turn may lead to improving organizational performance.
According to Patwardhan (2016), addressing unethical behavior among the physicians,
pharmacists, and pharmaceutical sales representatives resulted in increased transparency
in the relationships and interactions among these professionals.
Implications for Social Change
According to Wei and Delbaere (2015), patients have become skeptical about the
drugs that their physicians prescribe because some think that representatives of
pharmaceutical companies use the physicians as agents of persuasion to market their
prescribed brands. The results of this study may be beneficial to employees of the
pharmaceutical companies, physicians, and the patients they serve. Addressing unethical
behavior in the industry may enhance doctor-patient relationships and increase patient
trust in the pharmaceutical industry. Good relations and trust between health care
professionals and their patients may play a significant role in enhancing the quality of
health care and improving patient satisfaction (Allen et al., 2016; Birkhäuer et al., 2017;
Brown & Calnan, 2016; Hanse et al., 2016). The pharmaceutical companies can be a
power for a positive social change by supporting nonprofit organizations and academic
health care research through donations that bring future benefits to communities’ citizens.
A Review of the Professional and Academic Literature
Corruption is a persistent problem affecting the health sector with severe
implications on health status as well as social welfare (Salvioni et al., 2015). The
pharmaceutical industry has contributed immensely to the corruption problem in health
care and implies high risk to the social welfare (Badawi et al., 2015). Unethical behavior
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among the sales representatives is among the leading corruption factors in the
pharmaceutical industry (Villalba, 2019). The primary purpose of this section is to
provide critical analysis and synthesis of the literature related to the conceptual model,
and the strategies that sales managers in the pharmaceutical industry use to improve
ethical marketing training to reduce unethical sales representative behavior.
I provided this review of the professional and academic literature to help in
understanding the contexts in which managers may apply specific ethical marketing
strategies as well as to demonstrate why certain ethical training strategies may be more
important than others. I organized this review, so it includes six primary sections:
conceptual framework, causes and effects of unethical behavior, benefits of addressing
unethical behavior, challenges faced in addressing unethical behavior, relationship
building as the appropriate strategy for addressing unethical behavior, and training
strategies to reduce unethical behavior.
The strategy that I used was searching various databases and using the Walden
University Library to identify peer-reviewed articles and scholarly seminal books related
to the topic of interest. These databases were Science Direct, SAGE Journals, ProQuest
Central, ProQuest Dissertations & Theses Global, Google scholar, Expanded Academic
ASAP, ABI/INFORM Collection, Academic Search Complete, Business Source
Complete, Google Books, and Walden Library Books. I used various keywords and
phrases in the search. These keywords and phrases were as follow: ethical marketing,
training, strategies, business, unethical, pharmaceutical sale representative, behavior,
and general theory of marketing ethics.
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Conceptual Framework
For the conceptual framework of this study, I used the general theory of
marketing ethics. In 1986, Hunt and Vitell (1986) developed the general theory of
marketing ethics, and they explained decision-making processes that marketing managers
employed to resolve ethical conflicts. Hunt and Vitell used a combination of teleological
(intentional) and deontological (judgmental) assessments through their theory to create
ethical marketing strategies. Teleological assessment means the action is right if its
outcomes have benefits to the majority of others, whereas deontological assessment
means looking at the morality of action itself based on rules rather than based on the
consequences of that action (Hunt & Vitell, 1986).
The general theory of marketing ethics addresses the situation where a person
confronts a problem perceived to contain ethical content. The existence of an ethical
problem in a situation initiates the process (Hunt & Vitell, 1986). The model elements do
not apply if no ethical problem an individual identified in the situation. The general
theory of marketing ethics has helped in shaping research and knowledge development in
ethical marketing and decision-making procedure (Gresham & Ferrel, 1985).
The theory contribution to marketing ethics influences the field of business ethics
and marketing framework. According to Barnett (2001), ethical marketing consists of a
normative framework that researchers derived from philosophy. Barnett utilized the
normative framework elements to formulate decision models, principles, and research
scales (Barnett, 2001). Additionally, the descriptive models developed help to explain
organizational culture, managerial practices, and an ethical decision-making process.
Historically, scholars mostly reviewed issues relating to social and consumers’ protection
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aspects. During those times, Barnett addressed consumer protection features based on the
social and societal perspective and applied marketing ethics in decisions that profited or
protected stakeholders.
Hunt and Vitell (1986) focused the marketing ethics theory on addressing
comprehensive business ethics (i.e., moral obligations, standards, and individual
capability for good behavior). Based on Hunt and Vitell’s perspective, an individual
businessperson with positive moral behavior drives ethical behavior (Adams et al., 2001).
The normative approach to marketing ethics involves procedures for improving ethical
business procedures. Hunt (1990) defined a normative approach as trying to recommend
what marketing individuals or organizations ought to do or types of marketing procedures
a society ought to have. Thus, normative marketers emphasized “what can be.” Sims and
Keon (1999) indicated that a normative approach to marketing ethics can improve ethical
behavior. Therefore, the normative framework focuses on moral philosophies such as
justice, deontology, and teleology principles. Hunt further affirmed that the normative
approach entails universal moral responsibilities and a proportionality framework
concerned with intents and means of a decision. The approach also supports social justice
context which highlights that every individual has the freedom to choose their own
destiny and be treated justly by others (Gresham & Ferrel, 1985). Hence, the marketeers
using the normative framework advocate for acceptance of set core principles and moral
maxims. Marketeers use these elements as guide during the ethical decision-making
procedure. The normative framework based largely on individual values that family,
friends, and the community shaped.
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Teleological and Deontological Norms
The general theory of marketing ethics combines the traditions of teleological and
deontological theoretical ethical decisions (Hunt & Vitell, 1986). Based on this theory,
the business environment such as culture, the organization, personal influences, and the
industry impact how a person perceives an ethical decision. By applying deontological
theory, a person can examine whether the action taken during a situation is ethical. Hunt
and Vitell (1986) also indicated whether the action that is taken shows respect for the
rights of other people. This process entails comparing behaviors using a set of
prearranged deontological norms (Bass et al., 1999). These norms represent personal
behavior or values. The person then evaluates alternative actions using teleology norms;
this helps to identify the action that provides the most benefits.
Hunt and Vitell (1986) defined teleology evaluation as an examination of possible
consequences, the desirability of consequences, and the value of the stakeholder (Hunt &
Vitell, 1986; Weaver et al., 2000). For example, if the undesirable results of an action are
doubtful or if the desirability of affirmative results is higher than negative results; then
the person might decide to pursue the decision. This is because the teleological approach
emphasizes achieving the greatest good for the largest number of people. Using
teleological norms, the marketeers determine which participant benefits from the
decision; the people that might suffer damage, and if the good offsets the bad. An
individual’s approach to the action also plays a vital role in determining the person’s
actual behavior.
Marketing leaders considered situational restraints as an opportunity (Hunt &
Vitell, 1986). That is, if the person does not have an opportunity to become involved in a
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particular action, then the individual will be incapable to execute the action despite the
intention or ethical judgment (Waters & Bird, 1987). Hence, individual behavior results
from the actual consequences. These consequences become part of the individual
personal experience and an individual can relied this experience later for other ethical
problems. Despite the general theory of marketing ethics emphasize on normative norms,
critics state that the theory is too descriptive. However, the theory should be descriptive
in order to increase the understanding of normative factors (Hunt & Vitell, 1986). The
theory is not predictive; however, marketing experts use the theory to understand
cognitive processes associated with individual ethical perspectives (Barnett et al., 1998).
Hunt and Vitell (1986) described in their theory, the moral decision-making
aspects involved in ethical decision contests in organizations. Hunt and Vitell recognized
stakeholders’ value in using teleological evaluation. The general theory of marketing
ethics profoundly transformed the ethics landscape through its strict normative
background of moral philosophy. The general theory of marketing ethics contributes
largely to an individual decision-making process during situations which involve ethical
issues (Borkowski & Ugras, 1988). Based on teleology and deontology evaluation,
individuals can have various perceived alternatives and hence individuals are capable to
decide ethical actions. The evaluation process leads to behavior and intentions. Based on
that concept, an individual also recognizes that ethical judgment, behavior, and intention
are not always completely consistent.
The general theory of marketing ethics is consistent with general consumer
behavior theories; Hunt and Vitell (1986) suggested that ethical decisions impact
individual behavior by intervening intention variables. Hunt and Vitell recommended in
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the model of the general theory of marketing ethics that marketeers using both intentions
and ethical decisions are better analysts of behavior in a situation where ethical aspects
are essential rather than peripheral. The researchers also affirmed that ethical decisions
sometimes differ from intention because teleology valuation also affects intentions
independently (Adams et al., 2001). When marketeers developing intention and behavior
that are inconsistent with the ethical decision, feelings of guilt exist (Hunt & Vitell, 186).
Having two thoughts that are inconsistence called cognitive dissonance (Hinojosa et al.,
2017). Individuals can resolve cognitive dissonance through different methods to restore
consistency (a) changing one of the thought that caused dissonance, or (b) changing
behavior that related to inconsistency, or (c) adding a new thought that help rationalize
inconsistency, or (d) trivialize the inconsistency (McGrath, 2017). Negative
consequences of cognitive dissonance motivate to resolve inconsistency (McGrath,
2017). The sales managers provide ethical considerations to sales representatives when
performing their practice but their strategies tend to become unethical due to illegal
transactions and relations with the physicians, hospitals, or clinics (Ameer et al., 2019;
Badrinarayanan et al., 2019a; Sasirekha, 2018). Therefore, it is imperative to conduct an
empirical research to determine the actions and strategies done by sales managers in
addressing the concerns shown by their sales representatives. I used the general theory of
marketing ethics as a lens to explore strategies to improve marketing training for ethical
marketing to reduce unethical behavior of sales representatives in the pharmaceutical
industry.
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Action Control
Action control entails the scope to which an individual applies control in the
enactment of intent in a situation (Barnett et al., 1998). Marketeers using situational
restraints might have behavior that is inconsistent with ethical decisions and intentions.
For example, situational restraints such as sale opportunity may result in the adoption of
the alternative. Therefore, an individual should evaluate and then valuate of the actual
consequences of the chosen alternative to produce feedback based on personal
characteristics variable. Additionally, punishment and reward system could change
individual behavior when involved in an ethical content situation. Based on general
theory of marketing ethics, Donaldson and Dunfee (1994) affirmed that a person may be
accustomed to behaving ethically.
Factors that Influence the Ethical Decision-Making Process
Personal Attributes
Based on the general theory of marketing ethics, Hunt and Vitell (1986) identified
personal attributes that influence aspects of ethical decision-making procedures. For
example, individual religion influences ethical norms; people perceived as highly
religious individuals are also perceived as having more defined deontological norms.
These norms play a vital role in determining an individual’s ethical judgment. In
consumer ethics settings, Gundlach and Murphy (1993) identified that inherent religious
beliefs significantly determine consumer ethical beliefs. However, extrinsic religious
beliefs have little influence on individual ethical beliefs (Gundlach & Murphy, 1993).
Both extrinsic and inherent religious beliefs entail individuals integrating religious norms
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and faith in everyday life. These beliefs are a source of social support, status, and selfjustification.
Personal Values
A person’s value also influences the decision process. Gresham and Ferrel (1985)
examined numerous values that influence the decision-making process. For example,
managerial commitment represents a value that determines the decision-making process.
Companies with high ethical values have employees who are more committed to the
firm’s welfare (Gresham & Ferrel, 1985). However, individuals can exhibit high ethical
commitment because of organizational values. Therefore, companies should make the
decision-making process and organizational commitment values the top priority
(Gresham & Ferrel, 1985).
Personal Beliefs
Based on the general theory of marketing ethics, Hunt and Vitell (1986) also
focused on beliefs that reflect on how individuals believe the world works. For example,
to what magnitude does a person believe that self-interest exclusively motivate
individuals is one way a person may believe the world works. Using a moral viewpoint,
individuals believe that other people look at ethical egotism as a guide. Hunt and Vitell
proposed, in their theory, that the extent to which a person believes in ethical egoism and
self-interest approach is how the world works; this belief influences individual behavior.
Hence, individual moral character strength is a vital moderator of relations between
behavior and intentions. Additionally, role models are important in developing an upright
moral character. Thus, individuals with good moral character have the strength to behave
in consistent ways using a set ethical judgment (Bass et al., 1999).
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Cognitive Moral Development
Based on Hunt and Vitell (1986)’s study, a cognitive moral development level has
an influence on the ethical decision making process. The higher phase of cognitive
development indicates the greater capability to reason through difficult ethical situations
(Adams et al., 2001). Hence, individuals with high cognitive moral development bring
more deontological standards during any situation and would consider the interest of
people (with higher job rank) in their decision-making process. Some people are ethically
conscious, while others never recognize ethical issues involved in the decision-making
process.
Cultural Environment
Hunt and Vitell (1986) recognized that ethical problems exist in a business
framework, hence they explored ethical issues in marketing. Thus, Jones (1991) metioned
that Hunt and Vitell emphasized the general theory of marketing ethics on the importance
of the cultural environment that influences the ethical decision-making process. Based on
the general theory of marketing ethics, companies have complex norms which form a
structure where individuals socialize (Hunt & Vitell, 1986). Additionally, the general
theory of marketing ethics provides a structure for expounding on people’s moral codes,
distrust, and belief as parts of the cultural environment in such a company.
Personal Moral Principles
The general theory of marketing ethics holds that personal moral principles differences
result from variances in the following:


The rules for merging teleology and deontological evaluations.



The deontological standards held.
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The comparative significance of specific norms.



The procedures for solving conflicts among norms.



The procedures for interpreting norms applicability in certain situations.



The significance weights allocated to a specific stakeholder.



The rules for linking teleological components.



The supposed positive (highly significant) or negative (very insignificant) values
for a stakeholder.



The apparent probabilities of both negative and positive values for a stakeholder.
Some personal moral principles emphasize deontological norms, whereas others

emphasize teleological norms. Considering personal moral norms implied by neoclassical
traditional in economics, every person is a utility gauge which interprets self-interest
maximization (Roozen et al., 2001). In the general theory of marketing ethics framework,
deontological valuation is null, and individuals formed all ethical decisions based on
teleological valuation (Roozen et al., 2001). Moreover, the essential weights allocated to
stakeholders other than individual’s aspects are assigned null (Roozen et al., 2001). Thus,
in the neoclassical tradition, all individuals have personal moral values that guide them to
select the alternative that portrays the highest score (particularly in high restricted
teleological evaluation procedures where the importance weights for stakeholders other
than an individual) (Roozen et al., 2001). For example, based on the economics cost
transaction, economic man is a more delicate; deceitful person and self-interest pursuing
person (Weaver et al., 2000). In cost economics transaction, homo economics maximizes
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self-interest and the opportunistic astuteness (Weaver et al., 2000). Therefore, universal
opportunism is ubiquitous even among less opportunistic people (Weaver et al., 2000).
Some personal moral values spawn distrust, particularly when the society has the
dominant culture (Barnett, 2001). Dominant culture focuses only on teleological
evaluation; hence, with null importance weights for all stakeholders other than an
individual, social belief cannot exist. The more individuals accept the neoclassical
paradigm as their behavior guide, the more their capability to sustain a market economy
is weakened (Barnett, 2001). However, if personal moral values assume that utility
maximization spawn distrust, then which moral values present trust? Personal values in
terms of the general theory of marketing ethics model emphasized deontological
evaluation as a key component of ethical decision making. Predominantly, based on the
general theory of marketing ethics, an individual can argue that moral values based on
deontological ethics embrace society’s dominant culture that sustains social trust. When
society shares moral values based on deontological morals, trust can exist. When trust
exists in a society, individuals avoid attributes such as cheating, dishonesty, stealing and
shirking. Additionally, the culture will emphasize ethics that contribute to community
development (Barnett et al., 1998).
Application of the General Theory of Marketing Ethics
Hunt and Vitell (1986) mentioned that using the general theory of marketing
ethics in the classroom fosters ethics-education outcomes. These ethics-educations
outcomes include


Encourage learners to understand and potentially review in a reflective approach
their moral values.
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Enable learners to perceive moral conflicts, responsibilities, and issues; this is
helped by developing deontological norms.



Assist learners to understand moral aspects based on a situation; the instructor
(based on the theory) directs the students to focus on moral aspects involved in
the decision-making process.



Help learners to handle moral conflicts and issues; by providing students with
integrated tools and experience when analyzing ethical dimensions in the
classroom.

Ethical Perspectives Embodied in the General Theory of Marketing Ethics
Hunt and Vitell (1986) recognized that resolution of any ethical problem depends
on the philosophical perspective applied by the decision maker. Each perspective
contains its own inherent limitations thus Hunt and Vitell emphasized the theory as
combining more than one philosophical approach when resolving ethical problems. For
example, in the theory, Hunt and Vitell combined two main philosophical approaches;
teleological and deontological, to resolve ethical issues hypothesized by marketing
managers. The theory attempts to define constructs and interrelations inappropriate
details in order to guide the study of marketing decisions relating to ethical problems.
Deontological evaluation involves the assessment of the inherent virtue of each substitute
being deliberated for adoption. Individuals conducted the valuation by using personal
values prompted by the ethical problem of each alternative.
Conversely, teleological evaluation measures the badness or goodness of
consequences which might result from the implementation of each alternative (Waber &
Gillespie, 1998). Teleological valuation analysis considers desirable and credibility of
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each alternative, for example, consumers not getting the anticipated value from a product
because of inaccurate advertisement. Hunt and Vitell (1986) specified interrelations and
constructs that enable individuals to focus on portions during initial testing. Hence, this
model entails developing scenarios that present ethical problems and provides numerous
alternatives to resolve ethical problems. The central claim of the proposed model portrays
decision-making procedures that have ethical content. Equivalently, Donaldson and
Dunfee (1994) claimed that, based on the general theory of marketing ethics model, the
proposed relationships among core variables; accurately and significantly reflects the
approach in which individuals resolve ethical problems. Thus, Hunt and Vitell proposed
that


Deontological values considerably influence deontological evaluations.



The desirability of action consequences considerably impacts teleological
evaluations.



Ethical decisions are considerably impacted by teleological and deontological
evaluations.



The intent to implement a certain alternative is considerably impacted by the
ethical decision and teleological assessments.
In addition, Hunt and Vitell (1986) suggested that teleological assessment entails

the function of desirability of consequences, probable consequences and the significance
of stakeholders. Therefore, teleological and deontological valuations, undertaken
together, explain the higher ratio of variance in ethical decision-making than when taken
separately (Weber, 1992). Hence, based on the general theory of marketing ethics, the
individuals might not adopt an ethical alternative if the action does not lead to one or
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more desired results. In such a condition, the individual’s teleological assessment of the
results might be primarily influenced by intentions. Thus, the ethical decision might vary
from intentions because teleological valuations can independently affect intentions
construct. The mutual impact of teleological and deontological procedures is the norm
because in some situation a person might favor one action over the other. However,
Chang (1988) found that teleological assessment contained the strongest impact on
ethical decision-making and intentions. This transpires because personal moral
development level might impact the type of decision process. For example, a manager
might look for an alternative in order to identify which action is wrong and right.
However, an individual in a higher position might have high-level moral development
that internally helps to determine what is right or wrong (Neil, 1990).
The specific procedures applied during the decision-making process impact the
process and criteria used in resolving ethical issues. Individuals determine the marketing
decision process based on information sources preferred and how they can process that
information. Therefore, marketing styles may estimate teleological or deontological
approaches used to resolve ethical problems (Weber, 1996). Thus, the general theory of
marketing ethics helps individuals to understand the situation under which a specific
valuation process may dominate. Most of ethical problems might not be selected because
the action might lead to some desired consequences being also confirmed (Hunt & Vitell,
1986). This happens because the intent to adopt the alternative is only influenced by
ethical decisions and teleological assessments. I used the general theory of marketing
ethics (including utilitarian and deontological factors or assessments) as a lens through
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which to explore strategies to improve marketing training for ethical marketing to reduce
unethical behavior of sales representatives in the pharmaceutical industry.
Causes and Effects of Unethical Behavior Among Pharmaceutical Sales
Representatives
Unethical behavior in the pharmaceutical industry has become a common practice
that has captured the attention of many individuals and groups and has had severe
implications (George, 2016; Skandrani & Sghaier, 2016). For instance, patients have
become skeptical about the drugs that their physicians prescribe because some think that
representatives of pharmaceutical companies used the physicians as agents of persuasion
for the prescribed brands (Wei & Delbaere, 2015). In such instances, some patients may
prefer generic drugs to the prescribed brands or may choose to avoid the pharmaceuticals
entirely in favor of alternatives such as natural remedies.
Patients attributed unethical behavior among the sales representatives to the
profession itself, which is viewed as a subculture on its own (Bush et al., 2017). Unlike
other professionals, sales representatives are employees who work in an increasingly
complex and multifunctional environment that may provide numerous opportunities for
unethical behavior (Bush et al., 2017). For example, sales representatives may come
across customers demanding bribes or commissions from them to buy their products
(Button et al., 2018; Lord & Levi, 2017; Raj & Roy, 2016). Also, sales representatives
may be under pressure by supervisors and senior managers to bring in more business,
which influences them to focus on numbers at the expense of other attributes such as
ethics and integrity (Zhou et al., 2016). Therefore, it is critical to observe unethical
behavior among the sales representatives from the lens of the environment in which they
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operate because sometimes they are only doing what must be done (de Andrade et al.,
2018).
Pharmaceutical markets are characterized by a derived demand process in which
intermediaries (physicians) influence the end consumers (patients) to purchase the
product (Yehya, 2016). Therefore, pharmaceutical companies’ sales representatives may
have used push strategies to influence the physicians to prescribe their drugs to the
patients (Suebphanwongs, 2016). Push strategies are a fast approach to transfer a
customer (physician) from awareness to purchase (Suebphanwongs, 2016). There is a
difference between push and pull strategies. Salespersons use a push strategy to push a
product at a customer. Oppositely, using a pull strategy is to pull a customer towards a
product (Suebphanwongs, 2016).
The relationship between the physicians and the sales representatives determines
the speed of adoption of new drugs (Matikainen et al., 2017). Thus, positive relationships
may facilitate early adoption while negative relationships may delay the adoption of
drugs. However, not all researchers published studies support this view. For instance,
Fickweiler et al. (2017) indicated that most physicians do not believe that their
interactions with pharmaceutical companies’ sales representatives influence their
prescription habits. Therefore, the physicians indicated that they can distinguish between
marketing strategies and scientific facts about new drugs (Fickweiler et al., 2017). Also,
the physicians mentioned that medical and governmental institutions had developed
guidelines and self-regulatory checks to regulate the relationships between physicians and
the pharmaceutical companies’ sales representatives (Fickweiler et al., 2017). According
to Hewett and Krasnikov (2016), the quality of relationships between physicians and
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pharmaceutical companies’ sales representatives declines in the presence of authoritative
mechanisms. Preventing undue influence on physicians by the pharmaceutical
companies’ sales representatives is among the objectives of having those regulations in
place (Fickweiler et al., 2017).
The unethical behavior in the pharmaceutical industry is complex and
multifaceted and thus society cannot entirely blame the sales representatives (Brown et
al., 2016; Robbins, 2018; Taylor et al., 2016). For example, there are instances where the
physicians expect favors to prescribe certain drugs to the patients (de Andrade et al.,
2018). In such cases, even the ethical sales representatives may be influenced to avoid
losing business, which can result in financial losses. As long as there is intense
competition in the industry, there will always be companies with unethical sales
representatives ready to meet the demands of the physicians that expect favors.
According to Skandrani and Sghaier (2016), unethical behavior in the
pharmaceutical industry can arise from job characteristics, corporate, situational,
personal, stakeholder, or cultural factors. Kadic-Maglajlic et al. (2019) mentioned that
micro-level (personal), meso-level (corporate), and macro-level (industrial) factors
influenced ethical behavior. However, sales representative personal moral as well as the
industrial ethical environment are more positively associated with customer satisfaction.
On the other hand, corporate and industrial ethical norms have a combined stronger effect
on customer orientation compared to each of the ethical climates alone. Therefore,
training employees to enhance personal ethical behavior may not necessarily result in
high customer retention, especially if the overall ethical climate in the industry is
wanting. Besides, Kadic-Maglajlic et al. (2019) further noted that moral equity by a sales
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representative correlates strongly to customer orientation, but strong moral equity beliefs
can result in weaker sales outcomes when applied in situations requiring adaptive selling.
Benefits of Addressing Unethical Behavior
Pharmaceuticals have to play a vital role in the recovery of the ailing health care
sector (Salvioni et al., 2015). Addressing unethical behavior in the industry may lead to
better customer relationships and trust in the pharmaceutical industry as well as
physicians. Good relations and trust between the health care professionals and the
patients play a significant role in enhancing the quality of health care (Allen et al., 2016;
Birkhäuer, et al., 2017; Brown & Calnan, 2016; Hanse et al., 2016). Training sales
representatives on ethical marketing practices to avoid unethical behavior will make the
pharmaceutical industry more trustworthy, which will enhance health care quality. In
some countries, pharmaceutical companies’ sales managers are focusing more on
building ethical behavior and ensuring that employees understand the organizations they
work for (Lőrinczy & Formánková, 2015). So, this is important because developing trustbased long-term relationships between buyers and sellers requires ethical behavior among
the sales persons as well as the other people involved in the sales within an organization
(Ingram et al., 2015).
Incorporating the training and development programs into business processes and
marketing strategies increases the impact of training on the competitiveness of a firm
(Cloutier et al., 2015). Incorporating the ethical marketing training and development
programs meant to reduce unethical behavior will likely improve the competitive
positioning of pharmaceutical companies. The relationships that the pharmaceutical
companies’ sales representatives build after the training, will create more loyal
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customers, and result in increased sales when the managers incorporate ethical marketing
training program in the overall business strategy (Cloutier et al., 2015).
Researchers indicated that unethical behavior in the pharmaceutical industry must
be addressed because ethics play a key role in determining the performance of any
business entity (Aziz et al., 2016; Barrett et al., 2017). However, some of the measures
intended to address the unethical behavior in pharmaceutical companies such as the topdown directives have been ineffective, necessitating the need for more dynamic
intervention mechanisms such as the training of employees on ethical marketing to
reduce unethical behavior (Barrett et al., 2017). Ethical marketing training enhances trust
and loyalty with customers (Barrett et al., 2017).
Although interactions between physicians, and pharmaceutical representatives
may bring benefits to the health care industry, they influence the drug prescription and
dispensing activities, which can be detrimental to the quality of care given to the patients
(Hajjar et al., 2017). Therefore, it is important that policy makers come up with new
policies to regulate the interactions between the physicians, pharmacists, and
pharmaceutical sales representatives and penalize misconduct. Such policies will not only
ensure ethical conduct among the health care professionals in the pharmaceutical industry
but will also protect the patients from the challenges that might arise from unscrupulous
drug prescription activities that may have results such as developing drug resistance.
Following the challenges associated with the interaction between the physicians,
pharmacists, and pharmaceutical sales representatives, some experts have recommended
the cutting of links between physicians and the pharmaceutical industry. However,
researchers recommend establishing ethical guidelines indicating how the interactions
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should have a better approach (Gupta et al., 2016). These ethical guidelines should
include detailed information to indicate the extent to which the professionals can interact
and the things they should not do as a result of the interaction. Although the ethical
guidelines can minimize unethical behavior while maintaining the interactions between
health care professionals, there is no guarantee they will follow it.
Addressing unethical behavior among physicians, pharmacists, and
pharmaceutical sales representatives will result in increased transparency in the
relationships and interactions among these professionals (Patwardhan, 2016). For
example, mandating that the pharmaceutical sales representatives provide full disclosure
of the gifts they give the physicians, and mandating the physicians to disclose the value
of the gifts they receive will make it easier to determine the extent to which a physician’s
prescription actions are influenced by aggressive marketing activities by the
pharmaceutical representatives (Grundy et al., 2018). Sometimes the physicians are
unaware of the social psychology used by pharmaceutical sales representatives to
influence their prescription activities (Patwardhan, 2016). Therefore, establishing ethical
guidelines would protect the physicians from social psychology manipulations by
pharmaceutical sales representatives (Giacomini et al., 2016; Rios et al., 2016; Tobin,
2018; Wallang & Taylor, 2018). I used the general theory of marketing ethics as a lens to
explore strategies to improve marketing training for ethical marketing to reduce unethical
behavior of sales representatives in the pharmaceutical industry.
Challenges Faced in Addressing Unethical Behavior
Systemic failures have contributed to the ineffectiveness of the measures adopted
by pharmaceutical companies’ sales managers to deal with the unethical behavior of sales
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representatives (Barrett et al., 2017). Ethical dilemmas emerge, making it difficult for the
sales representatives to choose the ethical route when marketing their company’s
products (Musto et al., 2015). For example, stiff competition in the industry can influence
sales representatives to offer incentives such as commissions or bribes to the physicians
to prescribe drugs from their companies and thus meet the sales volume targets. Hence,
the ethical dilemma indicates that sales representatives and sales managers will often
have to make decisions regarding whether to follow the ethical route and compromise
business or follow the business route and compromise ethics. Depending on the
performance of the sales team and the existing market conditions, ethical dilemmas may
arise, making it challenging to address unethical behavior in the pharmaceutical industry.
Researchers indicated that many physicians have not read the ethical guidelines
indicating how they should interact with pharmaceutical sales representatives (Gupta et
al., 2016). Therefore, the ethical guidelines established to limit unethical behavior in the
pharmaceutical industry and health care organizations have not been implemented
because only a few of the professionals they are intended for have read, or follow them.
Therefore, it is important that policy makers ensure that the ethical guidelines they come
up with to regulate interactions between physicians, pharmacists, and pharmaceutical
sales representatives are adopted by these professionals. It is better not to have the ethical
guidelines than have them and fail to implement them. Therefore, stringent measures
should be undertaken to ensure that all physicians, pharmacists, and pharmaceutical sales
representatives read the ethical guidelines intended to ensure ethical interactions among
them.
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Some pharmaceutical sales representatives believe that the pressure on them to
ensure ethical behavior when interacting with the physicians is because of the lack of
understanding by their sales people. For example, pharmaceutical representatives have
been criticized for giving gifts to the physicians because it is seen as a way of bribing the
latter as their objective is to push their drugs (Patwardhan, 2016). Therefore,
pharmaceutical representatives holding onto this way of thinking cannot critically
consider the ethical guidelines meant to ensure effective interactions with physicians and
other key stakeholders in pharmaceutical and health care industries.
Mangers at pharmaceutical companies are greatly involved in funding medical
education and research (Harris, 2017). Consequently, many physicians have a
relationship with the pharmaceutical industry because they are involved in medical
education. If the world was perfect, physicians and researchers would operate without
money from the pharmaceutical industry (Harris, 2017). However, the world is not
perfect and thus the physicians and medical researchers need the money offered by the
managers at pharmaceutical companies. Unfortunately, the managers do not provide the
funding as a sign of good gesture but a purchase of influence (Harris, 2017). Therefore,
the physicians benefiting from the funding from the managers at pharmaceutical
companies either in research or medical education are more likely to prescribe drugs from
those companies even when there is pressure for them to embrace ethical standards.
Driven by sales and revenue objectives of the pharmaceutical companies, sales
representatives will continue to encourage physicians and medical researchers to enroll in
projects funded by the pharmaceutical companies and in the process earn their affection,
which can influence prescription habits (Kamal et al., 2015; Gautam & Pan, 2016).
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Marketing leaders should continuously address emerging ethical issues (Jain et
al., 2017; Sonnerfeldt & Loft, 2018). However, managers at the pharmaceutical
companies have not been able to update their code of ethics regularly to keep up with the
emerging unethical issues among pharmaceutical sales representatives, pharmacists, and
physicians (Ichikawa & Clayton, 2016). Therefore, the existing ethical guidelines (by the
American Marketing Association) cannot be sufficient in addressing the unethical issues
facing the industry. To update the code of ethics (Code of Conduct from the American
Marketing Association) regularly, managers at pharmaceutical companies may require
ethics experts who understand how the pharmaceutical industry operates, especially the
interactions between physicians, pharmacists, as well as pharmaceutical sales
representatives (Latten et al., 2018). The purpose of the continuous review of the code of
conduct should be to provide regulatory guidelines to deter new and emerging unethical
practices among the pharmaceutical sales representatives.
Sales managers at pharmaceutical companies have not done enough to empower
their sales representatives on how to identify and address ethical violations (Emran,
2015). There are various ways that pharmaceutical managers can empower their
employees to address ethical issues such as implementing ethics-training programs for
existing and new employees (Fickweiler et al., 2017). Addressing unethical behavior will
remain a challenge as long as the ethics-training programs remain insufficient.
Ethical Marketing as the Appropriate Strategy for Reducing Unethical Behavior
Unethical issues by the pharmaceutical representatives may include falsifying
daily call reports, misusing samples, as well as making disparaging remarks about the
competitors (Skandrani & Sghaier, 2016). Bribing of physicians by the sales
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representatives to prescribe their medicine to patients is another ethical issues in the
pharmaceutical industry (Skandrani & Sghaier, 2016). The researchers have indicated
that unethical behavior is among the issues ailing the pharmaceutical industry and is thus
relevant to my study. Ethical marketing training can be an effective strategy for reducing
unethical behavior in pharmaceutical companies.
Durable customer relationships in business-to-business sales environment have
emerged as an important aspect in today’s business environment (Schwepker, 2015).
Building strong customer relationships requires ethical behavior among the sales
representatives or corporations to earn the trust of the customers and develop sustainable
relationships (Agnihotri et al., 2016; Cuevas et al., 2016; Johnsen & Lacoste, 2016; Yoo
& Arnold, 2016). To ensure ethical marketing and behavior among the sales
representatives and empower them to make ethical decisions that improve sales
performance, sales managers at pharmaceutical companies should evaluate the ethical
loopholes among the sales representatives and come up with the ethical marketing
training programs to reduce unethical behavior.
Social media has emerged as a powerful technological tool for business-tobusiness relationship building (Niedermeier et al., 2016). Therefore, sales representatives
for pharmaceutical corporations should consider social media as an alternative to offering
incentives and bribes to the physicians to prescribe their drugs. Social media is becoming
a widely accepted communication tool for business. Social media provides real-time
engagement between sales representatives and the customers. Managers of
pharmaceutical corporations should thus train sales representatives on social media for
ethical marketing as an alternative way. If the sales representatives succeed in ethical

34

marketing and building long-term productive customer relationships, they will manage to
meet their sales targets and avoid the unethical behaviors they engage in to meet the
targets such as bribing of the physicians.
Leaders viewed trust as an important factor in defining provider-patient
relationships (Patwardhan, 2016). Therefore, the openness of the patients to the health
care providers, mainly physicians, about their problems is based on trust. Therefore, the
patients trust that physicians will use the information to provide the best diagnosis and
prescribe the most appropriate drugs (Birkhäuer et al., 2017). However, to maximize the
profits, pharmaceutical companies benefit from the sale of drugs that require physicians
to prescribe their drugs to the patients. Physicians may be influenced by pharmaceutical
sales representatives to provide prescriptions that favor certain pharmaceutical
corporations, which would amount to unethical behavior (Patwardhan, 2016). Therefore,
physicians face many moral dilemmas in deciding whether to provide prescriptions they
best believe would address the patient’s problem or those preferred by representatives of
pharmaceutical corporations. To avoid this problem, pharmaceutical sales representatives
should avoid giving gifts to the physicians and instead ethically marketing the drugs and
establish relationships of trust they can use to explain the benefits of their drugs
(Fickweiler et al., 2017). On the other hand, physicians should develop a relationship of
trust with the patients and sales representatives of various pharmaceutical companies in
order to understand the benefit of each drug and thus prescribe the right amount to the
right patients (Fickweiler et al., 2017).
Under relationships of mutual understanding, physician can have the confidence
to explain to a sales representative of a given pharmaceutical company why the physician
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prescribed a drug from a different company (Brax et al., 2017). Therefore, relationships
of trust based on ethical marketing should exist between physicians and the sales
representatives of different pharmaceutical companies to ensure that the drug prescription
process is transparent (Patwardhan, 2016). In the event that the condition of a given
patient can be treated using drugs from different companies, the physician can ensure
balance in the prescription to prevent favoring a particular company over others and thus
eliminate suspicions of engagement in corrupt or unethical practices (Patwardhan, 2016).
I used the general theory of marketing ethics as a lens to explore strategies to improve
marketing training for ethical marketing to reduce unethical behavior of sales
representatives in the pharmaceutical industry.
Training Strategies To Reduce Unethical Behavior
Training has been an essential corporate function because of the role it plays in
the development of turning employees into leaders and enhancing their skills (Hussain &
Soomro, 2018). Training and development play a critical role in developing a cohesive
workforce that is loyal to the organization (Cloutier et al., 2015). Also, formal training
and development teach the employees the need to adhere to the code of ethics of their
organization, so they embrace ethical behavior. Unethical behavior in corporations and
sales organizations is more prevalent than it has been before 2015 (Ingram et al., 2015).
These sentiments are like those mentioned by Wei and Delbaere (2015) who indicated the
value of intensive training of pharmaceutical companies’ sales representatives leads to
the sales representatives avoiding unethical behavior. Unless managers take
precautionary measures, skepticism can result in customers influencing one another to
rely on natural remedies and other alternatives to pharmaceuticals. Therefore, it is fair to
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say that Wei and Delbaere’s research is of great value to the study because they projected
unethical behavior as a threat to the future of the pharmaceutical industry. So, there is a
need to train pharmaceutical companies’ sales representatives on ethical marketing to
reduce unethical behavior.
The presence of sales representatives engaging in unethical behavior when
marketing pharmaceuticals to physicians could be an indication that many sales managers
in the pharmaceutical industry lack effective strategies for ethical marketing training to
reduce unethical behavior. Sales representatives encourage unethical behavior because of
the repetitive incidence of failure in making profit (Bolander et al., 2017). Therefore,
sales managers should direct the code of conduct measures and guidelines adopted to
address the unethical behavior. Managers should ensure addressing these factors while
training their sales representatives on ethical marketing and relationship building to
reduce unethical behavior. Skandrani and Sghaier (2016) indicated that undertaking
training programs to prevent the negative effects of unethical behavior and enhance
ethical awareness among medical representatives would be a necessary action that would
improve the reputation of pharmaceutical companies and result in the development of
long-term business relationships. However, Skandrani and Sghaier have not specified the
kind of training programs that sales managers should undertake and implement.
Nevertheless, researchers in other recent studies have attempted to fill the research gap.
For example, Sridhar and Lyngdoh (2017) conducted a study on 192 pharmaceutical
salespersons and indicated that information sharing influenced ethical marketing
behavior. Therefore, sales managers should consider sharing drugs’ adverse events
information as one of the critical ethical marketing training areas. This training area may

37

reduce unethical behavior for the sales representatives. Schwepker (2015) indicated that
direct and indirect ethical leadership through salesforce socialization enhanced the
performance of a sales representative. Moreover, the managers need to regularly remind
the sales representatives about the need to always act in the best interest of the customer
(Bolander et al., 2017).
According to Ingram et al. (2015), the best ethical marketing training strategy to
reduce unethical behavior should involve six steps: (a) assessing the marketing training
needs, (b) setting the training objectives, (c) evaluating the training alternatives, (d)
designing the marketing training program, (e) implementing the marketing training, and
(f) conducting follow-up and evaluation of the training. Undertaking marketing needs
assessment is important to determine the specific performance-related skills, perceptions,
attitudes, as well as behaviors required for the success of the marketing team (Ingram et
al., 2015). Researchers have defined ethical behavior components in literature (Ou et al.,
2015). Honesty, non-harassment, privacy, security, and avoiding overharvest are
components that define ethical marketing behavior (Ou et al., 2015). Ethical training
programs to reduce unethical sales representative behavior should focus on instilling the
values that reflect the stated ethical behavior components to enhance the quality of
customer relationships (Ou et al., 2015). The assessment would thus reveal the need to
change or reinforce one or several behavior components of sales team performance. In
the assessment of the training needs, it is imperative to determine the knowledge, skills,
as well as the abilities the salespeople need to have to meet both the sales team level and
organizational level goals and objectives.
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In most cases, organizations have been reactive rather than proactive in
undertaking sales training (Ingram et al., 2015). Therefore, the training often occurs when
the managers recognized the decline in performance either through a drop-in sales
volume, increasing costs, or lack of morale. So, it is an ineffective way because the
training should be undertaken to prevent such problems from arising and thus ensure
sustainable growth in the productivity of the sales team.
For the training to be effective, the sales managers should conduct the needs
assessment and consider the training that is appropriate for different salespersons such as
entry-level salespersons as well as the experienced salespersons (Ingram et al., 2015).
Different tools for the needed assessment are available such as sales team audit,
performance testing, sales team survey, customer survey, and job analysis among others.
The sales managers who conducted the correct sales assessment will determine the
success of the other steps outlined in the sales training process based on the results of the
sales assessment.
Integrating training and development programs in the business strategies of
pharmaceutical companies would help the sales managers get the support they need
regarding resources and personnel and thus manage to train the pharmaceutical
companies’ sales representatives on ethical marketing and building relationships while
reducing unethical behavior (Cloutier et al., 2015). Therefore, managers of
pharmaceutical corporations should ensure the incorporation of training and development
programs in the overall business strategies. As such, managers assigned resources to the
programs during budgeting, which enabled the managers to continually train the
pharmaceutical companies’ sales representatives on ethical marketing to reduce unethical

39

behavior. With adequate budgets for the program, the managers can hire trainers and
outsource trainers specialized in specific fields whenever necessary. However, it is
important to note that the effectiveness of the training of the pharmaceutical sales
representatives to influence them to avoid unethical behavior will depend on factors
beyond the training programs adopted. For instance, the training programs may not work
in instances where the sales representatives have remunerated on commission basis
because acting ethically would result in loss of income (Barrett et al., 2017).
Providing education to employees in a classroom setting has been used to train
employees on a number of issues such as importance of working in teams, embracing
ethical behavior, and having emotional intelligence among other critical issues
facilitating the success of staff members (McEwan et al., 2017). Because managers used
the strategy successfully in training employees in many settings, we can consider this as
an approach that may work in various situations. Therefore, sales managers at the
pharmaceutical companies can utilize it in training their sales representatives on ethical
marketing to reduce unethical behavior. The sales managers should set up classroom
settings within their premises and require the sales representatives to attend the lessons
on ethical marketing at specified times. The managers at the Human Resource
Departments should greatly be involved in the arrangements for employee training and
ensuring that all sales representatives participate.
The managers can use interactive workshops as employee-training strategies
(McEwan et al., 2017). They involve the employees participating in various activities in
an interactive environment in which other participants can react to such actions in the
most appropriate way to complement the doer or provide opportunities for improvement
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(McEwan et al., 2017). This strategy is perhaps the best in training pharmaceutical sales
representatives on ethical marketing. The sales managers can require the sales
representatives to attend workshops and may take up roles of sales representatives,
physicians, and pharmacists, and interact in ways that can improve marketing and avoid
unethical behavior. The objective of the workshops should be to identify activities to be
avoided and those to be upheld in practice.
The sales managers trained the employees and used simulation training in which
teams experientially enact teamwork skills such as interpersonal communication and
coordination in an environment that mimics upcoming events (McEwan et al., 2017). The
managers also can use the same strategy to train employee on relationship building as
part of the ethical marketing (McEwan et al., 2017). Various relationship building skills
may include interpersonal communication in an environment that mimics upcoming
events such as interaction with physicians from a given district.
Transition
In Section 1, I presented the background of the problem, the problem statement,
and purpose statement. The nature of the study includes justifications for selecting the
research method and research design. Then, I provided the research question and
interview questions. After that, I discussed the conceptual framework for this study, and
mentioned some operational definitions, assumptions, limitations, and delimitations. The
discussion related to the significance of the study included contribution to effective
business practice and contribution to positive social change. The review of the
professional and academic literature contains a critical analysis and synthesis of various
sources and content of the literature to convince readers of depth of inquiry.
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Section 2 includes the purpose statement, role of the researcher, and information
related to selecting participants for this study. Also, I provide information related the
research method and research design. After that, I discuss the population of this study and
the method of sampling. The ethical considerations include a discussion that focus on
maintaining the privacy and confidentiality of this study participants. Then, there is a
discussion of the data collection instruments and techniques, data organization
techniques, and data analysis. After that, I explain the methods of ensuring reliability and
validity of this study.
Section 3 includes the finding of this study and application to professional
practice. Then, I present implications for social change and my recommendation for
action. After that, I provide a discussion that covers my recommendations for further
research, reflections, and the study conclusion.
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Section 2: The Project
Purpose Statement
The purpose of this qualitative multiple case study was to explore strategies that
some sales managers in the pharmaceutical industry use to improve marketing training to
reduce unethical sales representative behavior. The targeted population consisted of five
sales managers located in the northeast region of the United States from three
pharmaceutical companies who have successfully used marketing training strategies to
reduce unethical sales representative behavior. The implications for positive social
change include the potential to develop strategies to reduce unethical behavior in the
pharmaceutical industry, which in turn may lead to more trust between patients and their
physicians, improving patient satisfaction, and promotion of prosperity for the
community through enhancing the quality of health care.
Role of the Researcher
According to Yin (2018), researchers play an integral and critical role in all steps
of research project. They are the main actors who manage all research steps from
planning to documentation, revision, and submission (Henderson, 2018; Hoddy, 2019).
The researcher is responsible for the data collection such as interviews of the target
respondents (Pinkelman & Horner, 2017). I explored strategies that some sales managers
in the pharmaceutical industry use to improve marketing training to reduce unethical
sales representative behavior. I was the primary instrument in all steps of this research
study (e.g., study plan, collecting and analyzing data, result interpretation, writing
conclusion, and documentation). My role in this research was to propose a plan for the
empirical study and then carry out the plan to complete the study. After I had the
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approval of the proposal from the institutional review board (IRB) at Walden University,
I started collecting the data. I discussed with the participants their role in this research
(e.g. answering my interview questions) and made sure they understand. I used openended questions to have in-depth phone interview with the participants (sales managers).
Also, I collected the related documents (e.g., marketing strategies they used, articles and
documents related to the marketing strategies, and memos) that participants may provide
me. After the data collection, transcription of the interviews was the next step I conducted
before the data analysis.
Researchers must have extensive knowledge and understanding of the topic they
are discussing to ensure the quality, reliability, and validity of the study (Råheim et al.,
2016). The relationship between the researcher and the researched topic must be deep to
properly carry out the study and this is the reason why researchers should have the
freedom to choose their topic. (Clancy & Vince, 2019; Råheim et al., 2016). In the
academic setting, the professors let their students choose their topic within the limits of
the program to ensure that the researchers will value their study because it has a deep
connection with them or they have strong interest towards their chosen topic.
Furthermore, Van den Besselaar and Sandström (2019) indicated that independence of
researchers gives them greater opportunities to showcase their skills in research.
Independence of researchers also promotes productivity because the researchers have
their own pace in conducting their study. I have more than 5 years of experience working
in the pharmaceutical industry. However, I did not make my opinion and experience
working in the pharmaceutical industry affect the results of this study. In addition, I did
not have any relationship with the potential participants in this study. Furthermore, I
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mitigated bias and avoid viewing data through my personal lens or perspective. Van
Manen (2017) used epoché-reduction phenomenon to decrease bias during conducting the
research. I used the same approach (epoché-reduction phenomenon) to reduce bias in my
research. I had to understand the topic of the research and be conscious so my bias and
knowledge did not affect the results of the research. According to Birt et al. (2016),
researchers use member checking to minimize their bias. To continue to combat bias, as
member checking, I sent a summary of the analyzed data to the participants to increase
the accuracy and minimizing bias.
According to Arifin (2018), researchers should include ethical considerations in
the research process to ensure the privacy and security of the human subjects
participating in research. In this study, I treated all participants in an ethical manner and
followed the ethical principles and guidelines for the protection of human subjects of
research, the Belmont Report (HHS.gov, 2016). Every potential participant who wanted
to voluntarily participate in this research received the informed consent. In addition, to
maintain the participants’ confidentiality, I saved the data in a USB memory stick locked
with a password. No one has this password except me. I keep this USB memory stick and
all paper documents, including those received from participants, in my locked home
office cabinet for 5 years. After the 5 years, I will destroy all data related to this research
by deleting all soft copy files on the USB memory stick and shredding all hard copy
papers.
Having an interview protocol helps to improve and standardize the interview
processes while conducting research (Castillo-Montoya, 2016). I created an interview
protocol (see Appendix A) that I used as road map while conducting this study. The
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interview protocol has information related to the interview preparation, opining the
interview, how I provided the informed consent to participants, conducting the interview,
theme verification, and coding. The interview protocol also includes how to proceed to
ending the interview with the participants.
Participants
The target participants must be properly identified based on the prescribed
research design (Saunders & Townsend, 2016). After identifying the number of
participants, a researcher conducts sampling to achieve the target number of respondents.
In my research, the targeted population consisted of sales managers located in the
northeast region of the United States. The eligibility criteria for study participants are (a)
sales managers, (b) located in the northeast region of the United States, and (c)
successfully used marketing training strategies to reduce unethical sales representative
behavior. Sales managers are the ones who manage the sales representatives. They have
direct connection to the sales representatives who sell the pharmaceutical products to
their target consumers (Levihn, U., & Levihn, 2016).
Before sales managers train their sales representatives, sales managers also
undergo rigorous trainings and evaluations to determine their credibility and capabilities
in leading their team (Zoltners et al., 2019). The high-level management team demands
that sales managers learn and understand the courses of actions done in the field so they
would know any unethical incidents occurring in the market (Deeter-Schmelz et al.,
2019; Demir & Min, 2019; Plank et al., 2018). Furthermore, the role of managers is vital
in leading and influencing the sales representatives (Inyang et al., 2018). Therefore, it is
necessary for these leaders to know how to well manage their subordinates. Leading and
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influencing the sales representatives justifies the need to examine the strategies
performed by sales managers to improve marketing training to reduce unethical sales
representative behavior.
Researchers selected sales managers as participants because they manage the sales
representatives (Huggins et al., 2016). I selected sales managers as participants in this
research because they are the ones who have extensive knowledge on the behavior and
performance of their sales representatives (Cheng & Ho, 2019; Martin et al., 2018). Sales
managers are also the ones who provide strategies that addresses the concerns (e.g.,
unethical behavior) surrounding their pharmaceutical industry. Through interviewing
these sales managers, I provided a significant contribution to the understanding of the
role and actions made by the pharmaceutical leaders in reducing unethical sales
representative behavior.
For gaining access to participants, I searched on LinkedIn’s professional network
website to find sales managers located in the northeast region of the United States. I did
not have any relationship with these potential participants before sending them
invitations. Then, I sent an invitation to each potential participant. The invitation included
the objective of the study, the procedure of the research, and what I expect from the sales
managers if they agree to participate. The participation in this study is voluntarily and no
monetary compensation for participation. In case if the sales managers agree to
participate, I emailed them the consent form that contains my contact information, so
they can contact me for further clarifications. In addition, I arranged an introductory
phone call to explain the informed consent in detail and to provide more information
upon request. Establishing a working relationship with participants is critical. So, after
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the introductory call, I made myself reachable by phone and email to answer any further
questions and to address all their concerns, if any, related to this study.
Research Method
According to Yin (2018) and Glenna et al. (2019), there are three types of
research methods: qualitative, quantitative, and mixed. Blaikie (2018) indicated that
qualitative research method cannot justify the generalizability of its results due to a
limited number of respondents and the mode of collecting data. However, according to
Bansal et al. (2018), qualitative researchers collect data and derive themes from the
research participants’ responses. Yin mentioned that qualitative research qualitative
research dwells on various lenses, ideologies, perspectives, statements, and arguments
that bring new light to the phenomenon. According to Cecez-Kecmanovic et al. (2020)
and Windsong (2018), qualitative research promotes critical engagement to the
respondents to delve deeper into the phenomenon. A qualitative research method was
appropriate for this study because I delved deeper into the perspectives and opinions of
the sales managers and derived themes from the research participants’ responses.
Researchers use quantitative research method to focus on the correlations between
two or more quantitative variables (Yin, 2018). Also, in quantitative research method,
researchers synthesize the data by focusing on the numbers obtained from the
performance, actions, or behavior of the respondents (Stafford & Farshadkhah, 2020).
According to Magruk (2015), quantitative researchers test hypotheses to examine the
relationship among variables. Therefore, a quantitative research method was not
appropriate for this study because I did not examine the relationship among variables.
According to Archibald (2016) and Yin (2018), both quantitative and qualitative methods
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are components of the mixed research methods. The mixed research method was not
appropriate for this study because I collected qualitative data from the interview
narratives to analyze and answer the research question, the use of quantitative data was
just for verifying the actual success of the strategies and identifying the principal themes.
Research Design
These research designs have specific use based on the target results, research
purpose and questions, as well as the data collection process (Yin, 2018). There are four
primary types of qualitative research designs: case study, ethnographic, narrative, and
phenomenological. (Harrison et al., 2017). I used a multiple case study design because I
explored several cases (not only one case) in depth within their real-world environments.
Researchers often use qualitative case study research design in social and life sciences
(Heale & Twycross, 2018).
According to Baker (2018) and Yin (2018), the goal of a case study is to
determine the development occurring in an individual, group of people, institution,
community, or organization. According to Moriarty et al. (2019), case study, as a
research design, receives various debates for its credibility and validity. However, case
study research design remains to be a significant method used in conducting different
kinds of research. Researchers using a case study design may not include a large number
of respondents but they can provide extensive information to answer the research
questions through its cases.
Case study researchers delve deeper into the situation, condition, position, and
status of their cases to obtain the most significant and interesting information (Zhu,
2018). I used a case study research design to determine the development of strategies
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used by sales managers in reducing unethical sales representative behavior. Through a
case study, I identified the perspectives of the sales managers and used their ideas for the
development of strategies used to address the identified concerns in the pharmaceutical
industry (i.e., unethical sales representative behavior). Furthermore, the case study paves
way to understanding the possible similarities and differences of strategies used in
addressing the unethical sales representative behavior.
Researchers use the ethnographical research design to collect information related
to the culture (Ferraro & Andreatta, 2017). The goal of using an ethnographical design is
to observe people living in a specific culture (Baskerville & Myers, 2015; Yin, 2018). I
did not focus on exploring cultures, so the ethnographical design was not appropriate for
this study. Another research design is the narrative. Researchers use narrative research
design to focus on personal stories (Hamilton et al., 2017). The narrative research design
is the appropriate one when the objective is providing a narrative context from real life
stories provided by the research participants (Shapiro, 2016). I did not collect and explore
life stories, so a narrative design was inappropriate for this study. Qualitative researchers
use phenomenological research design to focus on the live experiences of the research
participants (Nazir, 2016). Using a phenomenological research design results in providing
a phenomenon derived from the live experiences of participants (Daher et al., 2017).
Phenomenological design was not appropriate for my study because I did not describe the
personal meanings of the participants’ lived experiences.
Data saturation is time consuming, especially if new themes continue to occur
during the analysis (Saunders et al., 2018). However, researchers confirm the validity of
the findings through data saturation. Researchers reach data saturation when they cannot
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identify new themes from the analyzed data (Constantinou et al., 2017; Marshall &
Rossman, 2016). It is imperative for any qualitative research to reach data saturation and
ensure that there are no new themes arise from the analyzed data. In this research project,
I reached data saturation through continuing the interview with the participant sales
managers until there was a repetition in the information and no new information emerged.
Population and Sampling
I used the purposeful sampling method for this study. According to Duan et al.
(2015), using the purposeful sampling method help in leveraging inadequate resources
and selecting rich-information cases. Ames et al. (2019) indicated that researchers use
purposeful sampling to narrow down the inclusion criteria when a large amount of data is
available. In addition, Ames et al. provided the following steps to describe the process of
purposeful sampling: (a) identification of the study population (inclusion/exclusion
criteria), (b) selecting the sample size, (c) developing a sampling strategy, and (d)
recruiting individuals to participate in the study. I used the same steps provided by Ames
et al. to select sales managers who participated in my research.
The population of the study includes the sales managers in the northeastern region
of the United States. The northeastern region includes New England (Connecticut, Main,
Massachusetts, New Hampshire, Rode Island, and Vermont) and Middle Atlantic states
(Delaware, Maryland, New York, New Jersey, Pennsylvania, Washington DC, Virginia,
and West Virginia). There are 1,182 pharmaceutical companies in the northeastern region
with a minimum of five sales managers in each company (Crunchbase, 2020).
Considering these numbers, there was an advantage to focus on this region and to select
the target number of sales managers. The target sample size was five sales managers,
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from three pharmaceutical companies, who have successfully used marketing training
strategies to reduce unethical sales representative behavior. According to Boddy (2016),
the target number of samples depends on the acceptable sample size for qualitative
research. The interview (45–60 minutes) with sales managers was over the phone to made
it convenient for me and for the participants.
Ensuring data saturation, in this research, was through using the triangulation
method. Triangulation is collecting data from multiple sources to have a comprehensive
understanding of the topic (Khaldi et al., 2016). Triangulation is useful to reach data
saturation (Turner et al. 2017; Varpio et al., 2017). Qualitative researchers use
triangulation to increase the accuracy of the study finding and conclusions (Shoaib &
Mujtaba, 2016). I used triangulation and collected the data from multiple sources (e.g.,
interviews, internet, material provided by participants, etc.). According to Yin (2018),
qualitative researchers reach data saturation when no new themes develop from the data
analysis. I analyzed the data after each interview to find themes that I then arranged
together with data from the next interview and continued until reached data saturation. I
reached data saturation after the fourth interview, yet I completed the fifth interview to
confirm that data saturation occurred.
Ethical Research
Including human subjects requires ethical considerations because the researchers
must ensure the privacy and security of the participants (Yin, 208). According to Naidu
and Prose (2018), accountability is one of the ethical considerations in research because it
ensures that the researchers are accountable for any decision that may affect the privacy
and security of the participants. Kaewkungwal and Adams (2019) conducted a study and
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they emphasized the use of informed consent as part of ethical considerations in research.
Aside from accountability and informed consent, there are also concerns pertaining to the
privacy of the participants and confidentiality of the data, which I addressed in this study.
I am accountable for this research by taking all the responsibility in the research
process including the sampling, instrumentation, data collection, data analysis, and
documentation to ensure that privately and properly storage of all information provided
by the participants. I emailed the informed consent form to the potential participants to
ensure that they have detailed information related to the process of collecting data before
deciding whether to take part of this study. The informed consent contains the objective
of the study, background information, research procedures, some interview question
examples, and my contact information. I scheduled an introductory call with the potential
participants to explain the information available in the informed consent and to answer
any questions they may had.
The potential participants had one week to make their decision if they want to be
a participant in this study. During that week, I was available (by phone and email) to
answer any questions related to the study. If a potential participant agreed to participate,
he or she needed indicate his or her consent by responding to my email with the words “I
consent.” Then, a participant provided the time availability to conduct the phone
interview (45–60 minutes).
I included in the interviews only the individuals who email me their consent to
participate in my study. The informed consent stated that their participation in this
research is voluntary and no monetary or any other forms of incentive provided for
participating in this study. There are no obligations on the participant to continue the
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study and the participant can withdraw from the study at any time until the publication of
the results. If a participant decides to withdraw from the study, they can contact me by
email or phone.
In addition to the informed consent, there are several other measures that I used to
assure adequate ethical protection of participants. It is important to note that research
participants need to be ensured of their safety, especially in qualitative research wherein
researchers use the participants’ arguments, opinions, and ideas as evidence (Famenka,
2016). Researchers should keep the identity of the participants from the data collection to
the documentation of the study (Famenka, 2016). That was why there are numerous
actions I executed to ethically consider the human subjects. It is critical to keep the
privacy of the participants by keeping their information concealed. In the documentation
process, there was no personal information included to ensure maintaining the privacy of
the participants. I assigned a unique identifier to each participant. No data collection
occurred before I received final permission of the Walden University’s IRB. The final
IRB approval number is 05-27-20-0659768.
The next step was storing an excel sheet that linked the participant’s name and the
unique identifier in a USB memory stick locked with a password. No one has this
password except me. I properly stored the raw data in an encrypted file that I saved on the
USB memory stick to ensure the confidentiality of the data and maintain the privacy of
the participants. I keep the excel sheet (linking the participants’ names and identifiers)
and the data on separate secure devices. I will keep this USB memory stick and all paper
documents, including those received from participants, in my locked home office cabinet
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for 5 years. After the 5 years, I will destroy all data related to this research by deleting all
soft copy files on the USB memory stick and shredding all hard copy papers.
Data Collection Instruments
Data collection is an essential part of any empirical or experimental study because
it is the process that helps to answer the research question (Tin, 2018). The data
collection process determines the success of the study, which means that researchers must
execute proper considerations to achieve the target response and provide the preferred
result. According to Pinkelman and Horner (2017), the researcher is responsible for the
data collection process such as interviewing participants in research study and collecting
more data from other multiple sources. I was the primary investigator and the primary
data collection instrument in this research. The data collection process included
reviewing the company documents and reports provided by the participants (e.g.,
marketing strategies and memos) and semistructured interviews over the phone with five
sales managers of the three pharmaceutical companies in the northeast region of the
United States.
Researchers aim to delve deeper into the phenomenon through the subjective
perspectives and arguments of the respondents (Aguinis & Solarino, 2019). I asked
questions that delved into the subjective perspectives and arguments of the participants.
Semistructured interview is one of the common data collection instruments used in
qualitative research (Yin, 2018). Researchers use semistructured interviews and rely on
open-ended questions to have in-depth discussion with the study participants and gather
detailed information about the topic of interest (Castillo-Montoya, 2016; Nascimento et
al., 2018). Through an interview, the respondents think that their ideas, opinions,
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sentiments, and perspectives are valued because the researchers listen to their arguments
and comments related to the phenomenon (Aguinis & Solarino, 2019). However, it is
imperative to create an interview based on the purpose of the study (Arsel, 2017). This
means that the questions are solely based on the topic.
In this study, I focused on the purpose of the study by asking the interview
questions listed in Appendix B. The questions are based solely on being ones where the
answers are intended to answer the research question. In addition, I asked appropriate
follow up or probing questions that helped to have more clarification and to reach data
saturation. For each question, I made sure to give enough time to the participant to
respond. It is critical to follow the interview protocol (see Appendix A) in order to
standardize the interview process. The interview protocol (see Appendix A) contains
information related to interview preparation, opining the interview, conducting the
interview, and ending the interview.
Researchers enhance the reliability and validity of the data collection process
through member checking (Yin, 2018). According to Thomas (2017) and Britton et al.
(2017), qualitative researchers use member checking (sending a summary of the analyzed
data to the research participants) to confirm accuracy with each participant. I sent a
summary of the interview’s data analysis to each participation, so he or she could review,
add, or change, and confirm the analysis and to enhance the study’s validity.
Data Collection Technique
I collected the data by conducting semistructured interviews. According to
Castillo-Montoya (2016), researchers use a semistructured interview as a data collection
technique in qualitative research. Using semistructured interviews has the advantage of
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not having standardized script so the researchers use these interviews to collect in-depth
information from the study participants (Yin, 2018). Another advantage is the
opportunity to ask probing questions during the interview to collect more information
related to the topic (Goodman-Delahunty & Howes, 2016). When the interviewer express
opinions without limitations, the study participants are willing to develop a professional
relationship with interviewer (Smith & Sparkes, 2017; Yin, 2018). However, there are
several disadvantages of semistructured interviews including that they are time
consuming because it is an in-depth interview and I have to give each participant
sufficient time to respond to each questions. Furthermore, the researcher needs to have
proper skills and understanding of interviews process to conduct an effective interview
(Smith & Sparkes, 2017). I ensured that I had the required skills (by training) and
understanding the interview process to be able to conduct effective interviews with the
participants.
Following the interview protocol (see Appendix A) was critical to have
uniformity during the interview process, before, during, and after the interview.
According to Castillo-Montoya (2016), there are four steps for the data collection
technique (a) interview questions, (b) discussion based on queries related to the research,
(c) collecting feedback on the protocol, and (d) conducting a pilot study of the interview
protocol. I used the first three steps and ensured that my interview protocol met the
requirements of the IRB at Walden University.
Before the interviews, it was critical to ask the potential participants to sign the
informed consent that includes the information about the research. The informed consent
has information related to the objective of the study as well as the participants’
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contribution to the research. The informed consent also includes the procedures of
carrying out the data collection, which includes using a recorder as well as my I-phone as
back up of the phone interview with the participants. According to Yin (2018) and
Dankar et al. (2019), researchers are responsible to respect the study participants and
protect their right by providing an informed consent. I conducted the interview only with
participants who signed the informed consent.
After receiving the participant’s signed informed consent by email, I asked the
participants for their preferred time and date availability for the phone interview. I made
the necessary adjustments based on the participants’ availability to obtain the data.
However, the date must be within the interview period within one week after receiving
the informed consent to ensure that my timetable of the research remains consistent. I
conducted interviews based on the participants’ preferred date and time for their
convenience and comfortability. It was essential to consider the comfort and convenience
of the participants for them to provide quality information during the interview.
There were six interview questions to answer during the interview (see Appendix
B). The interview questions revolve around marketing training to reduce unethical sales
representative behavior, the framework to develop and implement ethical marketing
training, assessing the effectiveness of marketing training strategies, and the key
challenges in the implementation of ethical marketing training. I asked probing questions
to gather more information from the participants. According to Goodman-Delahunty and
Howes (2016) and Yin (2018), qualitative researchers ask probing questions during the
interview to obtain more information related to the subject matter of interest.
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The informed consent includes examples of the interview questions to help the
respondents consider their answers beforehand. The target time of the interview was
between 45 and 60 minutes, but I gave the respondents sufficient time to respond to each
question and provided quality information. At the end of each phone interview, I thanked
the participant for taking part in my study. After analyzing the collected data, I conducted
member checking by emailing a summary of the results to the participants and asking for
each person’s input. Using member checking helps to generate more data and increase the
validity of the study (Britton et al., 2017).
In addition, I used the data triangulation method and collected the data from
multiple sources (interviews, documents and reports provided by participants, interview
analysis, and member checking). The triangulation method helps to have more extensive
information related to the subject matter (Yin, 2018). Qualitative researchers use the
triangulation methods to help reach data saturation (Yin, 2018). However, Glasper and
Rees (2016) indicated that collecting data from several sources makes the research
process complicated. Moreover, confusion may result from reliance on multiple sources
to collect the data (Glasper & Rees, 2016). Therefore, qualitative researchers analyze the
data separately and then synthesize the data to identify the data similarities and
differences (Glasper & Rees, 2016). I conducted a systematic approach in collecting data
from multiple sources. After that, during the analysis, I identified the similar themes that
are related to my study.
Data Organization Techniques
Yin (2018) indicated that qualitative researchers collect the data, from the study
participants, and organize the data to prepare it for the next step, which is data analysis.
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According to Broman and Woo (2018), data organization is an essential step before
performing the accurate data analysis. Data organization is important because it allows
determining any gap that might have occurred in the data collection (Broman & Woo,
2018). The most significant aspect of data organization is the ability of the researcher in
transcribing all the data or responses of the participants (Yin, 2018). From the recorded
file, I transcribed the data into sentence or paragraph form in spreadsheets.
The next step was organizing the data by respondent answer to the questions,
creating a detailed information, and providing a general view of the similarities and
differences of the participants’ responses. I used NVivo® 12 to organize the collected
data. According to Houghton et al. (2016), qualitative researchers use NVivo® 12 to
organize and track the data which help in the next step, which is data analysis. After data
organization and coding, I highlighted the themes to identify any similar ideas shared by
the respondents.
Appelbaum et al. (2018) indicated that researchers should keep the research
related records and documents for at least 5 years. I stored all raw data securely in a in a
USB memory stick locked with a password. Then, I will keep this USB memory stick and
all paper documents, including those received from participants (e.g., informed consents
in case if I print them), in my locked home office cabinet for 5 years.
Data Analysis
The data analysis is the next step after the data organization. Data analysis in
qualitative research design is far different from quantitative research. Unlike quantitative
research wherein the prevalence of the case depends on numbers, the focus in qualitative
research is on the themes or quality of the information obtained from the participants
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(Simpson & Wilson-Smith, 2017). Some qualitative researchers examine the participants’
points of view as they share their knowledge and experience related to the topic
(Kozleski, 2017; Scharp & Sanders, 2019).
I used triangulation during data analysis to validate the interview data with
document data. Considering that I employed the qualitative research design, the most
appropriate data analysis method is thematic analysis. Theme development is essential in
qualitative research because researchers determine the relationship of the participants’
responses (Vaismoradi et al., 2016). The opponents of qualitative research argue that
thematic analysis does not pass the trustworthiness criteria because the responses are
subjective rather than objective (Nowell et al., 2017). However, qualitative researchers
use the thematic analysis to present valuable information on the situations experienced by
the study participants as they deal with the phenomenon (Oliveira et al., 2016; Yin,
2018).
Through similar ideas and themes, I identified the prevalence of the situation,
which justified the purpose of the study (i.e., exploring strategies that some sales
managers in the pharmaceutical industry use to improve marketing training to reduce
unethical sales representative behavior). I focused on the key themes and searched to find
literature related to these themes. I correlated the key themes with the literature
(including new research published since writing my study proposal) and the conceptual
framework.
After installing NVivo® 12 program on my Windows laptop, I followed Yin’s
(2018) logical and sequential process for the data analysis of the case study qualitative
research. I started analyzing the data by compiling the relevant collected data from
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multiple sources (interviews, documents and reports provided by participants). Then, the
next step was to disassemble data into separate categories. After that, I started data
coding and grouped the data into identifiable themes. The next step was interpreting the
data. The final step of data analysis was determining the conclusion.
Reliability and Validity
Reliability
The best way to address the issue of reliability is by conducting a follow-up of the
existing research to justify its consistency (DuBois et al. 2018; Matheson, 2019). In this
study, I promoted reliability by providing all the steps in conducting the research.
Therefore, interested researchers can replicate the study and justify its reliability. This
process can serve as a follow-up research to show that I offered justifiable data that other
researchers can use in studying the issues in the pharmaceutical industry, particularly the
unethical behavior of sales representatives and the strategies used by sales managers in
addressing these problems. Furthermore, the study is reliable based on dependability.
Dependability
A research is dependable if other researchers can replicate, audit, and critique the
research process because of its complete structure, discussion, illustration, and analysis.
Moon et al. (2016) defined research dependability as the consistency and reliability of the
research findings and documenting the research procedures, which allowing someone
outside the research to follow, audit, and critique the research process. By looking at that
definition, Moon et al. explained that dependability justifies the reliability of the study
through identification of consistency based on the discussion of the research procedures,
which give other researchers the interest to replicate the research process. In this study, I
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ensured its dependability by providing all the research processes conducted (e.g., data
collection sampling, and data analysis).
Member checking is a critical tool to confirm the accuracy of the research
(Thomas, 2017). Researchers use member checking and send a summary of the analyzed
data to the participant to generate more data and to confirm the accuracy of the research
results (Britton et al., 2017; Yin, 2018). Qualitative researchers improve the study
dependability by using member checking. In this study, I used member checking and sent
a summary of the results to each participant for review. Applying member checking in
this research increased its dependability.
Furthermore, I presented the ethical considerations to ensure proper
communication in recruiting participant and conducting the research. Also, it was critical
to show how I selected the samples and managed the research before, during, and after
the interview. Other researchers can use these procedures in replicating this study and
expanding the discussion to obtain more information on the topic.
Validity
A research is valid if the process of conducting a research depends on the
standards promoted by the research design, as well as the researchers that examine the
procedures done in the investigation (Cypress, 2017). The proponents of quantitative
research argue that it is difficult to validate a qualitative research because there is no
fixed result. However, it is important to note that “to validate means to investigate, to
question, and to theorize, which are all activities to ensure rigor in a qualitative inquiry”
(Cypress, 2017, p. 258). According to Yin (2018), it is critical for researchers to focus on
the validity of their study. Validity in qualitative research refers to the ability of reflecting
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the participants’ responses (Yin, 2018). I investigated through interviews, provide a
research question, present a theoretical framework, and establish reliable data collection
and analysis methods. These processes justify the validity of the study and strengthen the
obtained results from the investigation. Despite the subjectivity of results, the research
remains to be valid because of the consistent and accurate procedures done to obtain the
required data (Yin, 2018). This section includes credibility, transferability,
confirmability, and data saturation because these parts make up validity in qualitative
research.
Credibility
Research bias determines the credibility of the study (Yin, 2018). Credibility is
crucial in the establishment of the study validity. Some researchers demonstrate disputed
credibility because of their personal values, perspectives, preconceptions, and ideologies
instilled in the research. These issues must be avoided to ensure that the study is free
from any researcher bias, especially for qualitative research (Yin, 2018). Qualitative
researchers should avoid their preconceptions, personal beliefs, and ideologies while
analyzing the data to avoid bias (Marshall & Rossman, 2016). I made sure my view did
not affect the research process from collection of the data to interpreting the results and
writing the conclusion. I used the triangulation method and collected the data from
multiple sources (interviews, documents and report provided by participants, and member
checking). According to Marshall and Rossman (2016), qualitative researchers use data
triangulation to merge information collected from many sources.
To ensure the credibility of qualitative research, feedback must be considered
(Thomas, 2016). After analyzing the collected data, I used member checking by sending a
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summary of the results to the participants and requesting a response detailing any
changes they think I should include in the results, I requested a response from them
within 5 to 7 business days. According to Britton et al. (2017), researchers use member
checking to confirm the accuracy of the research results. Also, I augmented any
additional, appropriate data provided by member checking to increase the study
credibility.
Transferability
One of the significant goals of any empirical research is to contribute to the
research literature and fill the gaps in research (Yin, 2018). However, this is not the sole
purpose of any research that includes human subjects as sources of evidence. One of the
reasons why researchers conducting empirical studies need to provide a clear and detailed
discussion of sampling, data collection, and data analysis is for transferability (Yin,
2018). Transferability is the process of transferring the procedure to the setting of the
researchers who try to replicate the study (Korstjens & Moser, 2017). It is critical for
researchers to maintain transferability of their research to other settings (Marshall &
Rossman, 2016). Interested researchers should be able to transfer the procedure to similar
situations or contexts to enhance the study validity (Yin, 2018). Nonetheless, researchers
must not wait for other interested researchers to transfer the procedures and findings in
the study to prove its transferability. I made sure to include all important procedures and
findings in the documentation to ensure that other interested researchers can easily
transfer them into their own situation, research, or discussion. By providing clear
discussion of this study methodology, I ensured the study transferability.
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Confirmability
Confirmability is one aspect of validity (Mohajan, 2017). Confirmability refers to
ensuring that the findings depend on the statements shared by the participants rather than
the personal opinions and thoughts of the researcher (Johnson & Rasulova, 2017; Yin,
2018). Researchers establish confirmability by reducing their bias in the discussion of
findings (Korstjens & Moser, 2017). One of the issues considered in qualitative research
is researcher bias because the data is subjective, which the researchers can change to
provide their preferred findings (Johnson & Rasulova, 2017). Researchers using epochéreduction phenomenon to decrease bias during conducting the research increase the
confirmability of the study (Van Manen, 2017). I used epoché to decrease bias and
increase the confirmability of this study. With the issue of bias, it is necessary for me to
separate my personal views and beliefs from the result of this study (Yeomans, 2017).
Additionally, I used member checking to enhance the confirmability of this study.
Data Saturation
Data saturation is time consuming, especially if new themes continue to occur
during the analysis (Saunders et al., 2018). However, researchers confirm the validity of
the findings through data saturation. Researchers reach data saturation when they cannot
identify new themes from the analyzed data (Constantinou et al., 2017; Marshall &
Rossman, 2016). It is imperative for any qualitative research to reach data saturation and
ensure that there are no new themes arise from the analyzed data. In this research project,
I reached data saturation through continuing the interview with the participant sales
managers until there was a repetition in the information and no new information emerged.
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Transition and Summary
Section 2 includes the purpose statement, role of the researcher, and information
related to selecting participants for this study. Also, I provided a detailed discussion
focused on research method and research design. After that, I presented information
related to population and sampling. The population and sampling include the inclusion
criteria in selecting the participants of this study. The ethical considerations include
information related to maintaining the privacy of the participants and confidentiality of
the data in this study. The discussion on the data collection include a detailed illustration
of how I collected the data. Then, I discussed the procedures during and after the
interview. I ensured the clarity of the study methodology to encourage interested
researchers to replicate the study and strengthen the arguments presented in this research.
For the data analysis, I conducted thematic analysis using a computer program software
(NVivo® 12). Then, I mentioned the method to ensure reliability and validity of this
study.
Section 3 includes the finding of this study and application to professional
practice. Then, I present implications for social change and my recommendation for
action. After that, I provide a discussion that covers my recommendations for further
research, reflections, and the study conclusion.
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Section 3: Application to Professional Practice and Implications for Change
Introduction
The purpose of this qualitative multiple case study was to explore strategies that
some sales managers in the pharmaceutical industry use to improve marketing training to
reduce unethical sales representative behavior. The collected data include information
derived from sales manager interviews, documents, and memos provided by sales
managers at three pharmaceutical organizations in the northeast region of the United
States. I used the general theory of marketing ethics (including utilitarian and
deontological factors or assessments) as a lens through which to explore strategies to
improve marketing training for ethical marketing to reduce unethical behavior of sales
representatives in the pharmaceutical industry. Findings were consistent with the general
theory of marketing ethics. According to Gawronski and Beer (2017), individuals rely on
utilitarian (intentional) or deontological (judgmental) factors in forming their ethical
response to an action. Sales managers reported many strategies to reduce unethical sales
representative behavior. These strategies include developing ethical standards,
developing organizational policy, and having ethical training and development programs.
Presentation of the Findings
The research question for this study was what strategies do sales managers use to
improve marketing training for their pharmaceutical company representatives to reduce
unethical behavior? The collected data included recorded semistructured interviews with
five participants who were sales managers with successfully used marketing training
strategies that reduced unethical sales representative behavior. These sales managers
located in the Northeast region of the United States from three pharmaceutical
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companies. Each sales manager answered my six interview questions and other probing
questions during the interview. After the data transcription and data analysis, I used
member checking by sending a summary of the analyzed data to the participants and
requesting a response detailing any changes they think I should include in the results.
Using triangulation was critical in this study. So, I collected the data from
multiple sources (e.g., interviews, documents and memos provided by the sales
managers). After interviewing the fifth participant, I recognized that I reached data
saturation because no new themes emerged. I used the computer software program,
NVivo 12, to analyze the collected qualitative data. There were five steps for thematic
analysis (a) compiling the data, (b) disassembling the data, (c) reassembling the data, (d)
data interpretation, and (e) conclusion. These are the same five steps that Yin (2018) used
for thematic analysis. Three themes emerged (see Table 1) and subthemes under each
theme. I discussed each theme and subthemes in the findings.
Table 1
Strategies Implemented To Reduce Unethical Sales Representative Behavior
Strategy

Percentage of use by
participants (sales managers)

Developing ethical standards

100%

Developing organizational policy

100%

Training and development programs

100%
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Theme 1: Developing Ethical Standards
According to Sridhar and Lyngdoh (2017), relational selling behaviors and sales
performance are significantly influenced by ethical selling. In agreement with Sridhar and
Lyngdoh, P4 stated, “Ethics defines the relationships and operations of the
pharmaceutical industry and its practitioners.” P4 further mentioned that managers
perceived many sales force personnel to have innate weaknesses that revolve around
ethical issues. Sridhar and Lyngdoh found that the flow of information is an
indispensable aspect of ethical selling behavior. Sridhar and Lyngdoh defined flow of
information as the state of complete engagement in an activity by an individual to the
extent that they ignore everything else. I reviewed the training manual from P1, P3, and
P4’s companies, which contained information about ethic and salespersons’ behavior to
validate the interview data. P1 was emphatic when this report was given: sales people
may coddle unethical behavior owing to internal pressures of minimal supervision and
having to meet sales quotas. P1 indicated, “Developing ethical standards is critical in all
pharmaceutical companies to reduce unethical behavior.” P1 further mentioned that
ethical standards should include the boundaries of communicating and building relations
with external stakeholders during the process of marketing and selling such a product.
All interviewed participants developed ethical standards to promote ethical
behavior through a strong influence on the salesperson. P3 indicated that influencing
sales representatives helps in motivating them to maintain ethical measures at the
workplace. P3 was consistent with Miska et al. (2016) who explained that organizational
influences through ethical standard determined ethical behaviors. Therefore, managers at
pharmaceutical companies can minimize unethical sales representatives’ behavior by
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addressing the ethical concerns and related organizational influences that affect their
sales personnel. Malik et al. (2019) explained,
Ethical activities comprise an active engagement in literacy programs targeting
the medical community to influence the physicians’ prescription behavior to
improve sales. However, one of the obligations on sales representative in the
pharmaceutical industry is to adhere to the code of ethics. (p. 246)
Malik et al. further noted that, having a code of ethics is critical while communicating
and building the relationship with physicians during the pharmaceutical marketing. In this
study, three subthemes emerged from the strategy of developing ethical standards (see
Table 2).
Table 2
Subthemes in Developing Ethical Standards
Subthemes in developing ethical standards

Percentage of use by the
pharmaceutical company

Communication

100%

Building relationship

100%

Marketing and selling products

100%

Communication
P2 stated, “Ethical communication between stakeholders arise important in every
business.” P2 mentioned that communication is a critical method in promoting and
complying with the ethical standard of the business. In addition, all participants in this
study agreed that communication is vital and helps to engage stakeholders in the
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business’ code of ethic. Katamba et al. (2016) indicated that managers use key
performance indicators to show how the adoption of a business code of ethic and conduct
is essential in registering commercial feasibility void of any immoral practices. Katamba
et al. further mentioned that poor communication of the business code of ethics and
conduct creates intentional rebellion from the stakeholders, specifically the staff.
Excellent communication of the ethical standard generates universal acceptance and
creates strategic competitiveness, reputational improvement, and increased probabilities
of winning cross-border collaboration among concurring pharmaceutical players
(Katamba et al., 2016).
Shaw and Whitey (2016) asserted that managers at companies in the dynamic
business environment anticipate ethical standards and greater transparency. The
participants in the interview concurred that communicating effectively with stakeholders
increases their trust and confidence in the business and helps in compliance with ethical
standards. In addition, the participants mentioned that effective communication with
stakeholders can create transparent and ethical business environments that there is an
increasing trend towards stringent regulations that demand the detachment of commercial
from medical activities in pharmaceutical businesses. P4 indicated that separating
commercial and medical activities could be a requirement in some pharmaceutical
companies towards maintaining a code of conduct and ethics in fulfilling medical
activities to match regulatory requirements. However, P4 mentioned that effective
communication should help remedy unethical inclinations of staff in undertaking these
medical activities.
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According to Min et al. (2017), communication with stakeholders is part of the
corporate social responsibilities (CSR) initiatives conducted in pharmaceutical
companies. P5 mentioned that the CSR involves communication with the stakeholders of
a business to update them on corporate activities and events and the extent to which the
business is socially responsible to its internal and external stakeholders. P5 mentioned
that maintaining ethical standards embarking on transparency and greater ethical
foundations in communication with stakeholders provides a clear picture of the
organizational goals and contributes to controlling unethical behavior of staff (sales
force). P5 stated, “Transparent communication delivers business’s objectives to
stakeholders to achieve social, environmental, and economic goals.” P5 is consistent with
the triple bottom line mentioned by Min et al.’s study that is comprised of social,
environmental, and economic strategies that are in play to ensure managers manage the
business to produce an overall positive effect.
Building Relationships
According to Kazadi et al. (2016), building relationship with stakeholders has
been associated with creating benefits in pharmaceutical industries such as, exceptional
knowledge bases and resources. Kazadi et al. further indicated that stakeholder theory
relates to the development of organizational relationships with multiple stakeholders. The
participants in this study indicated that the high management teams at the organizations
remained informed about stakeholders’ concerns and integrated some stakeholders in the
decision-making processes. Kazadi et al. explained by saying that
Stakeholders stand as valuable sources of exceptional knowledge during the
innovation process. The stakeholders remain the locus of the firm’s innovation
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and innovation networks couple diverse aptitudes, knowledge, and resources
which are not necessarily available through market transactions. (p. 3)
Kazadi et al. further noted that, increasing complexity of products and services demands
the input of stakeholders to drive a firm’s capacity to manage its innovation networks and
subsequently improve its creativity and overall outcomes. P1 stated, “Building
relationships with stakeholders is critical and it should be based on ethical standards.” P1
further mentioned that through building relationships, stakeholders have the opportunity
to suggest ethical standards to be incorporated in innovation processes which may help to
minimize immoral practices among the employees.
Franco-Trigo et al. (2019) mentioned that building relationships and stakeholder
involvement optimizes promoting the integration and acceptability of new health services
as well as health planning. P5 asserted that collaboration with stakeholders facilitates the
overcoming of challenges associated with community pharmacy services. All participants
in this study confirmed that building relationships and active participation of stakeholders
in key organizational processes could help to maintain an ethical sales force in
pharmaceutical companies. In addition, Lorenzini et al. (2017) found that building
relations, long-term ailments, and engagement with stakeholders are valuable aspects in
driving innovative packaging solutions in the pharmaceutical industry. Building
relationships with stakeholders can help mitigate problems arising in packaging and
health care services (Lorenzini et al., 2017). Stakeholders can also contribute to
environmental aspects like user-friendliness and CSR, both elements of ethics (Lorenzini
et al., 2017).
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Marketing and Selling Products
Many researchers focused on ethical and unethical behavior in developed
countries and fairly highlighted the plight of these issues in emerging economies
especially in the pharmaceutical sector (Skandrani & Sghaier, 2016). Haque et al. (2019)
mentioned that patient-centric marketing strategies are increasingly used by managers at
pharmaceutical manufacturers to target medical practitioners prescribing medicines for
patients. Because patients are at the core of the health care system, 100% of participants
in this study agreed that ethical standards in marketing strategies, adopted by managers at
pharmaceutical companies, are an important aspect of ethical behavior. Javed and Ilyas
(2018) showed that presence of unethical standards in pharmaceutical-based marketing
strategies influenced patient satisfaction. P2 stated, “Marketing mix strategies of
pharmaceutical companies comprise various communication channels such as, the use of
electronic, mass, and print media as well as e-Detailing through literature.” P2 explained
that marketing communications of pharmaceutical companies are strictly regulated but
recent trends show a rise in unethical marketing practices among sales representative in
the pharmaceutical industry.
However, P1 indicated, “The religious core-values of the managers as well as
sales representative could have impact and influence on the process of marketing and
selling to make it ethical.” According to Haque et al. (2019), some religions endear
ethical considerations in patient-centric marketing strategies. Haque et al. revealed that
ethical standards in marketing enhance the health care service provider’s reputation.
Participants in this study said that prioritizing patient satisfaction through ethical
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marketing strategies and communications translates to increased market share and use of
service. Fatima (2017) indicated that
In the era of increasing competition among organizations, differentiation through
customer-centric and ethical selling is a plus. Sales personnel need to engage
honest actions that foster lasting relationships with customers and promote
customer trust and satisfaction with the marketing communication applied. (p. 69)
Fatima further noted that, marketing management should perceive the corporate social
audit as a chance to show its concern for the safeguarding of consumer rights. The high
management team can remove uncertainty surrounding the marketing function by
monitoring, assessing, prescribing marketing processes, and creating a marketing-centric
ethics code (Fatima, 2017).
Kadic-Maglajlic et al. (2019) mentioned that an ethical organizational climate
improves the optimistic impacts of the industrial ambiance on customer orientation.
Ethical marketing fosters ethical organizational climates that embody truth and ethics
when targeting customers (Kadic-Maglajlic et al., 2019). Interviewed participants in this
study concurred that ethical marketing and selling create an industrial climate that
positively impacts the organization’s reputation. The utilitarian perspective implies that
ethical actions are those that achieve the greatest good for the largest number of people
(Skandrani & Sghaier, 2016). Ethical marketing strategies have multidimensional
benefits for pharmaceutical industries, companies, practitioners, and customers
(Skandrani & Sghaier, 2016). All participants agreed that ethical marketing and selling
standards reduce unethical sales representative behavior in the pharmaceutical industry.
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Theme 2: Developing Organizational Policy
Mehralian et al. (2018) indicated that organizations with the ability to create and
amass knowledge according to organizational policy can sustainably compete. According
to Mehralian et al., pharmaceutical companies have all the characteristics accredited to
knowledge-based firms and managing knowledge in the industry is an important aspect
that contributes to organizational performance. Huang et al. (2017) asserted that
organizational implementation of ethical policies is a critical factor in realizing
registration and reporting of outcomes in clinical trials.
Huang et al. (2017) indicated that managers at pharmaceutical companies are
providing access to raw data in order to elevate the transparency of their clinical trials.
Huang et al. mentioned that policy embodies ethics and affords the stakeholders an
opportunity to scrutinize the full compliance of the data and its presentation with the
ethical code of conduct. Beck-Krala and Klimkiewicz (2017) explained,
Due to increasing concerns related to unethical behavior in the pharmaceutical
industry, organizations should have organizational policy to limit unethical
behavior. GlaxoSmithKline is an example of a pharmaceutical company that has
designed an organizational policy to reduce unethical behavior, improved work
processes, efficient resource consumption, and financial savings. (p. 48)
Beck-Krala and Klimkiewicz further noted that, organizational policy is valuable to
ensuring that sales representative in pharmaceutical companies perform their duties
within ethical bounds.
P5 stated, “Organizational policy goes hand in hand with ethical standards in such
organizations.” P5 indicated that organizational policy includes information that is crucial
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to reduce unethical behavior. P5 further mentioned that organizational policy represents
facets of information that managers should share in an organization. I reviewed policies
from P5’s company regarding organizational policy to validate the interview data. In
addition, all participants observed that organizational policy assuming the addition of
intellectual capital on ethics improving the ethical position of the business and
employees. Three subthemes emerged from the strategy of developing organizational
policy (see Table 3).
Table 3
Subthemes in Developing Organizational Policy
Subthemes in developing organizational policy

Percentage of use by the
pharmaceutical company

Preventing bribes and kickbacks

100%

Handing financial transactions

100%

Regulating activities

100%

Preventing Bribes and Kickbacks
Managers at pharmaceutical businesses considerably depend on aggressive
marketing strategies to obtain the loyalty of patients and physicians, which at times
embodies corruption (Peltier-Rivest, 2017). Therefore, there is a need to adopt counter
strategies ranging from using transformational leadership in employee help programs and
appraising performance goals associated with sales to providing certified employee
training on important company policies and antibribery laws (Peltier-Rivest, 2017). P4
stated, “It is very important to prevent all types of corruption including bribes and
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kickbacks.” P4 further added that instituting suitable anticorruption controls (separating
the sales function from the marketing division), encouraging whistle blowing and an
open-door policy, evaluating corruption risks linked to having business operations in
poorly performing regions, and sensing common corruption plots helps an organization
promote ethics in business dealings with physicians and clients.
Mackey et al. (2018) mentioned that health-sector corruption has created a
menace in the industry through inhibiting access to safe and effective medicines, quality
health services, and destabilizing systems targeting financial risk safeguards. Mackey et
al. mentioned that corruption slows progressive efforts aimed at realizing universal health
coverage. The World Health Organization estimated that close to U.S. $415 billion was
lost in health care abuse and fraud in 2008 (Mackey et al., 2018). All interviewed
participants said that organizational policy targeting corruption should facilitate ethical
behavior among practitioners and employees (i.e., sales representatives).
Researchers showed that corruption in health care has more than financial impact
and associates with a detrimental effect on individuals’ status quo and poorer health
(Mackey et al., 2018). P2 mentioned that many aspects make the health care industry a
corruption zone such as, sophistication of country-specific health care systems, the
internationalized nature of the health care supply chain, and information asymmetries that
can result in slackened decision-making. P2 indicated that internationalization of the
health care system increases the number of corruption access points. Participants in this
study agreed that instituting corruption free environments (penalties) could help
discourage organizational corruption. The participants mentioned that stakeholder should
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engage in fostering collaboration with industry players to mitigate the causes of
corruption.
P3 stated, “Formalized payment structures can help reduce corruption.” P3 also
mentioned the importance of implementing tight controls on payment methods and
procedures to ensure that managers handle medical finances effectively and accountably.
Implementing safer procurement and delivery procedures could also help prevent
kickbacks and bribes. P1 added, “Limiting supply chain intermediaries is a step towards
mediating risks associated with long supply chains and bureaucratic procedures.”
According to David-Barrett et al. (2017), third-party certification is another positive
commitment towards fighting health care corruption. Third-party certifiers like the
International Federation of Pharmaceutical Manufacturers and Association (IFPMA) are
global institutions whose commitment lies in promoting and supporting voluntary ethical
principles and practices in the pharmaceutical industry (David-Barrett et al., 2017). All
participants agreed that organizational policy which embeds anticorruption policies could
also help reduce sales representative and practitioner-based unethical practices in the
pharmaceutical industry.
Handing Financial Transactions
Witchey (2019) highlighted how managers at the health care sector can improve
transactions using validation systems. Witchey presented a block chain method of
handling financial transactions in the health care sector and found that conducting
financial transactions should include corresponding health care parameters such as,
clinical evidence, results, outputs, and inputs among other criteria. Validation systems
help to establish a transaction’s validity through the proof-of-work principle. Participants
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in this study mentioned that validation systems help to foster transparency of financial
health transactions thus ensuring minimal unaccountability of the system. The
participants also mentioned that validation systems help in generating coordinated data of
a patient by incorporating the patient’s history in the block chain. The participants further
indicated that managers can use level of coordination and responsibility to prevent
unethical practices among the sales force in the pharmaceutical industry.
Nunoo (2019) suggested an Enterprise Resource Planning System (ERPS) for
handling transactions. In Nunoo’s study, the use of an all-encompassing ERPS is the key
to reducing inefficiencies and optimizing business performance. Nunoo also showed that
the appropriate implementation of an ERPS ultimately increases business performance
and directly controls the optimization of revenue and sales in pharmaceutical companies.
Nunoo further asserted that the ERPS can provide important information to senior
management team that is comprehensible and applicable when formulating strategic
decisions to improve the performance of the business. Hassan and Daud (2017) posited
that eco-organization is an important facet of eco-innovation. Hassan and Daud defined
eco-organizational innovation as the upgrade of business’s management processes
through novel eco-methods in the firm’s practices. Eco-organization is linked with
enhancing corporate performance through enhancing employee and workplace
satisfaction levels, sustaining critical changes, reducing suppliers’ costs, and minimizing
transaction and handling cost (Hassan & Daud, 2017). P1 stated, “The use of transaction
handling methods and systems can significantly reduce unaccountability and the loss of
critical patient information.” P1 further mentioned that transaction handling methods and
systems also improve ethical working by motivating responsible behavior among
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employees concerning handling of patient and miscellaneous transactions in
pharmaceutical companies.
Regulating Activities
Researchers showed that there are many activities between physicians and
employees (e.g., managers, sales representatives) at pharmaceutical companies (Lotfi et
al., 2016). P3 stated, “The main benefits of activities between physicians and sales
representatives at pharmaceutical companies are rewards for services.” P3 further
mentioned that physicians in the pharmaceutical industry require motivation to perform
beyond expectations.
P4 indicated that physicians showed a positive appreciation and approval of these
conferences that managers at pharmaceutical companies’ sponsor. However, P4
mentioned that managers regulate conferences and other activities (through organization
policy) to reduce unethical behavior. All participants in this study agreed that knowledge
gained through conferences and stringent policies against excessive interaction between
sales representatives and physicians could reduce unethical behavior in the
pharmaceutical industry. The participants also mentioned that sales representatives
provided information regarding specific drugs to the physicians and used promotional
tools like sending direct mails, face-to-face interactions, and offering free samples for
distribution to patients. In addition, sales representatives use other activities (e.g., buying
dinners, event tickets, paying for meals and vacations for families, and honorariums) to
foster products during events and foster loyalty among physicians to certain products and
pharmaceutical companies (Alowi & Kani, 2018). All participants mentioned that
managers at pharmaceutical organizations have organizational policies that cover
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regulating activities between sales representatives and physicians to reduce the chance of
having unethical behavior.
According to Gupta et al. (2016), establishing organizational policy allows
physicians and sales representatives to know the extent of the ethics code of conduct and
to align their activities that include interactions and behavior accordingly. Alowi and
Kani (2018) suggested the important need to establish an organizational policy because of
the scrutiny of promotional activities (seminars, sponsored travel, exclusive gifts, etc.) by
sales representatives towards doctors. P2 stated, “The organizational policy should ensure
that doctors and sales representatives act in the best interests of the patients and
company.” P2 also mentioned that organizational policy that promotes ethical
interactions between doctors and sales representatives is vital to maintaining a strong
ethics code.
Theme 3: Training and Development Programs
Muddukrishna at al. (2018) indicated that training and competency levels play a
key role in ensuring the effectiveness of medical staff in pharmaceutical industries.
According to Muddukrishna et al., training and development are complimentary and
parallel to competency levels in the pharmaceutical industries. All participants in this
study said that training and development programs help employees to be more
determined to apply learned knowledge and skills in daily practice. Part of this
knowledge may include ethical training and conduct in the workplace. Therefore, having
these training programs reduce sales representative unethical behavior in the
pharmaceutical industry.
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Babapour et al. (2018) indicated that training provides non-technical skills like,
professional ethics, negotiation skills, behavioral skills, and organizational values among
others, which are relevant to increasing the effectiveness of employees in the
pharmaceutical companies who are medical practitioners. However, Dhainaut et al.
(2020) argued that training on the standard operating procedures remains inadequate.
Dhainaut et al. mentioned that enhancing the understanding of pharmaceutical companies
concerning the health care system and co-designing and co-constructing creative health
solutions are components of robust training and development programs. I reviewed
policies from P1, P4, and P5’s company regarding maintain ethical standards when
selling products. In addition, all participants indicated the importance of training and
development programs in reducing sales representative unethical behavior. There were
three emerged subthemes from the strategy of developing training and development
programs (see Table 4).
Table 4
Subthemes in Training and Development Programs
Subthemes in training and development programs

Percentage of use by the
pharmaceutical company

Training on ethical business practice

100%

Training on the standard operating procedures

100%

Building and sharpening skill set

100%
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Training on Ethical Business Practice
There is an increasing trend towards the institutionalization of training programs
in the pharmaceutical industry (Setia et al., 2018). Training may include an external
communication cycle comprising communicating data to a suitable audience, listening to
stakeholders to obtain insights, and gathering data founded on stakeholder necessities
(Setia et al., 2018). P3 stated, “Stakeholder input and needs assessment is essential in the
design and implementation of training program focused on ethics in pharmaceutical
industries.” P3 further mentioned that education is part of the training program in such
organizations. Setia et al. (2018) further indicated that advisory boards in the
pharmaceutical industry promote the generation of credible educational content. This
content is relevant to promoting ethical standards among industry professionals.
Sales representatives collaborate with health providers to focus on gaps in
educational needs or clinical practice and improving health and wellbeing of people
globally (Setia et al., 2018; Villalba, 2019). P2 mentioned the importance of the
collaboration between sales representatives and physicians. P2 stated, “Collaboration can
provide insight on ethics gaps in the industry and foster much needed change in the ethics
code of conduct for sales representatives.” P5 stated, “Sales representatives could rely on
such content to adapt their moral compasses to fit industry and business-specific
requirements.” P5 further mentioned that having training on ethical business practice
helps to reduce unethical behavior.
On the contrary, Chisholm (2019) posited that managers should react to
educational needs of sales representative to impart necessary skills and knowledge to
avoid unethical behavior. Industry requirements make imperative the development of

85
training programs for educational provisions that impart qualities like, analytical
thinking, innovation, self-direction, problem solving, and flexibility to promote industrial
growth and practicality (Chisholm, 2019). These skills could help minimize unethical
practices in the industry. Chisholm further suggested that disruption in health care is
affecting education to adapt the industry professionals to a volatile, uncertain, complex,
and ambiguous (VUCA) world. The interviewed participants in this study concurred with
developing ethics training programs to adapt medical practitioners and impart necessary
competencies that effectively engage them in positively changing the industry.
P4 stated, “Dynamism in the pharmaceutical industry also demands ethical
conduct when dealing with stakeholders.” P4 also mentioned that ethical business
practice is critical factor to combat unethical behavior among sales representatives.
Chisholm (2019) observed a need for increased training and education focus on ethics
business training. This training could impart moral considerations among sales
representatives to allow them to perceive the seriousness of unethical behavior issues
(Chisholm, 2019).
Training on the Standard Operating Procedures
Quality management is indispensable in the pharmaceutical industry because
employees need to follow standard operating procedure to comply with the regulatory
requirements and to avoid unethical issues (Sharma, 2017). P2 stated, “Following
standard operating procedures is mandatory for employees at pharmaceutical companies
to maintain ethical business practice and credibility.” P2 indicated that sales
representatives need to have quality management training to facilitate their duties. P2 also
mentioned that through training on the standard operating procedures, sales
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representatives engage in ethical practices while communicating with physicians. Also,
having a quality management system facilitates the execution of transparent, efficient,
and effective structure and processes that helps to achieve consistent compliance with
regulatory frameworks (Yaseen et al., 2018). Additionally, quality management systems
help the managers to realize customer satisfaction, improved quality, inspection
readiness, and optimized costs (Sharma, 2017).
P1 indicated that global regulators have found deficiencies in the way that some
pharmaceutical companies manage quality-control, standard operating procedures, and
training. P1 mentioned that there are many challenges with utilizing cross-functional data
and this is considered as a primary concern related to the standard operating procedures.
P1 stated, “These concerns reflect in the sales representatives of pharmaceutical
companies leading to operational inefficiencies and propagating unethical conduct.”
Shanley (2019) mentioned that improved standard operating procedures should help to
ameliorate problems in pharmaceutical companies and improve efficiency. P3 indicated
that the use of digital tools help individuals to refer directly to most appropriate standard
operating procedures, important data, and protocols. P3 also mentioned that training sales
representatives on the use of these digital tools can help them to effectively manage
reports, data, and discourage unethical conduct.
Pai et al. (2016) mentioned that personnel training for pharmaceutical industry
should include training on the standard operating procedures necessary for the
performance of delegated responsibilities and duties. Interviewees in this study
mentioned that standard operating procedures training allowed employees to perform
their duties without supervision and do so perfectly. Training on standard operating
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procedures also empowers employees to comply with the values of the organization
during the performance of their duties. This training could help sales representatives to
behave ethically as per the stated norms and standard operating procedures of a
pharmaceutical company.
Building and Sharpening Skill Set
Modern medicine focuses on effective and efficient provision of services and
products. In this era, the need for a competent and skilled workforce in pharmaceutical
industries is ever rising. Yusuff (2018) indicated that changes in the field of
pharmaceuticals focused on building the skill set of employees, deepening knowledge,
and sharpening the competencies of health care practitioners. Yusuff suggested that more
focus targets physicians and medical professionals are needed. These health care
professionals should ensure they absorb the culture of effective and safe prescribing,
consistent professional education, and logical use of medicines. Moreover, considerable
attention has been paid to enhancing the quality of facilities and pedagogical strategies
applicable when training health care professionals (Yusuff, 2018). This focused training
has helped to endear high standards of performance and ethics in meeting their
obligations.
P5 stated, “Building and sharpening skill set is meant to reduce unethical behavior
of medical professionals in the fields of sales and marketing.” P5 indicated that exposure
to learning opportunities continues to ensure that sales representatives engage in selfdirected metacognitive practices, formulate their own learning, and promote ethical
behavior. P4 mentioned that providing the opportunity to the employees to complete their
graduate study (e.g., master of business administration) helped sales representatives to

88
increase their knowledge and sharpening their wits to contribute to radical changes in
training, duty performance, and practice inside the company. P4 further mentioned that
building skill sets and sharpening competencies could continue to dissuade unethical
practices in the pharmaceutical industry.
From 2014 to 2019, there was a rise in dialogue between global regulators and
pharmaceutical manufacturers on the best ways to measure quality (Shanley, 2019).
Health impact assessments (HIAs) have been studied in relation to quality assurance in
health care. Green (2018) defined HIAs as tools for measuring the effect on a
population’s health and wellbeing of proposed policy and strategy. These tools include
training and how the training impacts health workers in performing their duties and helps
to maintain the quality of services offered by sales representatives and training received.
P2 stated, “Through HIAs, the level of training of the sales representatives can be
reviewed and appropriate suggestions made to effect necessary changes.” P2 further
indicated that it is possible that HIAs have an indirect impact on building the skill set and
sharpening the competencies of medical professionals, which is relevant to reducing
untoward behavior such as unethical behavior.
Alignment of Findings with the General Theory of Marketing Ethics
Marketing ethics is a subset of business ethics that focuses on ethical
circumstances of significance to the field of marketing. In the theory of marketing ethics,
Keig and Ferrell (2016) indicated that the stakeholders and prerequisites strongly
influence what comprises tolerable behavioral standards in marketing processes and
activities. The emphasis of this approach is concerned with how ethical principles are
applicable to marketing institutions, decisions, and mannerisms. Research indicated that
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the theory of marketing ethics has a wide scope ranging from ethics in corporate
decision-making, marketing aspects such as, product, place, price, promotion, global
marketing, marketing studies, regulatory, religion, ethical codes (Keig & Ferrell, 2016)
and consumer ethics, channel constraints, and product issues (Murphy, 2017). The
findings in this study indicate that marketing training exemplifies ethical considerations
and seeks to apply them in managing the behavior of sales representatives in the
pharmaceutical industry. Participants in this study agreed that sales representatives were
frequently engaged in marketing functions and events and hence uniquely positioned to
behave ethically or unethically. Corruption across pharmaceutical industry and businesses
indicates an urgent need for marketing ethics in training and performance of duties. Also,
appropriate identification and fulfillment of training needs for sales representatives is
required to influence their ethical perceptions of marketing and service functions they
perform.
Similarly, Gbadamosi (2019) indicated marketing ethics from two dimensions
citing scholarly works. Gbadamosi suggested the teleological and deontological ethical
approaches. Gbadamosi further mentioned that deontological ethics purports that it is
possible to determine what is right and wrong through referring to some autonomous
ethical code or a set of predetermined values. This approach in relation to the findings
shows that marketing ethics can be gained from an organization’s code of ethics or its
ethical values. It is thus possible for sales representatives to rely and comply with the
ethical code of conduct of an organization or its values in handling transactions,
procuring medication, and selling and marketing products. In contrast, teleological ethics
obtain moral obligation or duty from what is desirable or good as a necessary achievable
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end (Gbadamosi, 2019). This approach indicated that people, groups, or institutions have
a moral duty to seek to achieve what is desirable no matter the outcomes. In the
pharmaceutical industry, this symbolizes the current needs concerning ethical codes.
Medical representatives should aim fulfilling their duties ethically to achieve stakeholder
loyalty and build trust and confidence. Pharmaceutical companies as well should consider
aligning their activities (marketing, sales, etc.) with ethical underpinnings to achieve the
desired effect (more revenues and increases stakeholder satisfaction).
Applications to Professional Practice
Unethical behavior among pharmaceutical sales representatives is one of the
leading causes for corruption and financial fraud in the pharmaceutical industry (Villalba,
2019). The participants in this study mentioned that it is critical to improve training to
reduce unethical behavior of sale representatives. Pharmaceutical sales managers may use
the results of this study to develop effective marketing training strategies to reduce
unethical behavior of sales representative, which in turn may lead to improving
organizational performance. According to Aziz et al. (2016), managers in the
pharmaceutical industry must address unethical behavior because ethics plays a crucial
role in determining the performance of any business entity. Addressing unethical
behavior among the physicians, pharmacists, and pharmaceutical sales representatives
resulted in increased transparency in the relationships and interactions among these
professionals (Patwardhan, 2016).
Interviewed participants in this study agreed that expansion of ethical
considerations and increasing stringency of regulations in this sector promises both
patients and practitioners efficient delivery of services and products. The participants also
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mentioned that sales representatives in the pharmaceutical industry has shown great
promise in managing clientele prescriptions, conditions, and needs as regards
pharmaceutical products and services. Over time, the advancement of technology and
marketing strategies has significantly impacted this industry. Pharmaceutical industries
and companies have an array of digital tools coupled with conventional methods that
facilitate the provision of safe and efficient services and products. Innovation and other
activities such as co-creation with stakeholders and co-designing and co-construction of
health services has seen the pharmaceutical industry move forward in procuring efficient
health care and wellbeing of its dependents (Dhainaut et al., 2020). In an era of increasing
diseases and pandemics, the pharmaceutical industry continues to take charge in the
discovery and creation of new pharmaceutical products, their prompt and safe
development, and finally the manufacture and distribution of healthy and efficient
products (Siddiqui et al., 2017).
New constructs like eco-organization and eco-innovation continue to ensure that
the industry remains relevant in training and deployment of human resources and
products to meet patients’ needs (Hassan & Daud, 2017). Many interviewed participants
indicated that pharmaceutical companies keep the industry abreast with important
changes through strategies in marketing ethics, training, and service provision. The
participants also mentioned that developments like value-driven content creation provide
a wealth of web content for sales representatives and physicians to improve health care
and provide people with diverse pharma-based insights. According to Witchey (2019),
technological developments like the blockchain method of handling financial transactions
have expedited transactions and improved accountability in pharmaceutical companies.
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New training instruments like HIAs provide scrutiny of marketing training and other
training programs and help to check unethical standards in the industry (Green et al.,
2018).
Implications for Social Change
The results of this study may be beneficial to employees of the pharmaceutical
companies, physicians, and the patients they serve. Addressing unethical behavior in the
industry may enhance doctor-patient relationships and increase patient trust in the
pharmaceutical industry. According to Wei and Delbaere (2015), patients have become
skeptical about the drugs that their physicians prescribe because some think that
representatives of pharmaceutical companies use the physicians as agents of persuasion
to market their prescribed brands. Good relations and trust between health care
professionals and their patients may play a significant role in enhancing the quality of
health care and improving patient satisfaction (Allen et al., 2016; Birkhäuer et al., 2017;
Brown & Calnan, 2016; Hanse et al., 2016).
All participants in this study agreed that training on ethical business practices has
improved the quality of services provided to patients. This ensures that society is
protected from unscrupulous business activities through inculcation of ethical standards
in training, marketing, and duty performance. Implications from the findings indicate that
ethical standards are important in promoting accountability, building stakeholder trust
and confidence, and facilitating efficiency in pharmaceutical companies. Regulatory
compliance also ensures that sales representatives are ethically inclined when performing
their duties (Riggs et al., 2016). Studies show increasing expectations of the community
towards transparency and ethical standards in a dynamic business environment as
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exemplified by the pharmaceutical industry (Shaw & Whitney, 2016). The IFPMA works
with its member companies and country-specific associations to improve the agenda of
ethical conduct and self-regulation. According to Shaw and Whitney (2016), through
driving ethical considerations, the IFPMA has enabled pharmaceutical companies and
industries to promote ethical strategies and standards in their operations and activities
hence protecting the public’s interests.
Likewise, there is a need for pharmaceutical companies to maintain ethics to
assist them in providing safe and efficient health care products to patients (Dutt et al.,
2018). Sustainability is a concern in the pharmaceutical industry and can solely be
ensured via ethical practice. Research indicates that countries and health systems
continue to struggle with providing sustainable access to required medicines at a
universal level (Cernuschi et al., 2020; Vogler et al., 2018).
The participants mentioned that pharmaceutical companies can be a power for a
positive social change by supporting nonprofit organizations and academic health care
research through donations that bring future benefits to communities’ citizens. A number
of multinational pharmaceutical companies have engaged public-private alliances that
aim at enhancing access to medicines to all members of a population and simultaneously
generate social business (profits). However, pharmaceutical companies should be
concerned with practical and alleged conflicts of interest when intervening in systems
that can impact the present and future markets for their products. There is also a growing
need for feasible and compelling measurements tools, metrics, and structures to facilitate
the evaluation of social business interventions to improve medical circumstances (André
et al., 2018). Therefore, social interventions like marketing training, ethics education, and
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literacy programs targeting performance of duties in pharmaceutical companies are
relevant to improving the ethical angle of medical business activities. Implications from
these findings support social marketing that embodies ethical standards in helping sales
representatives, in the pharmaceutical industry, to behave ethically in various situations.
Social marketing seeks to benefit the universal community and target audience
much less the marketer through influencing social behavior (Bakan, 2016). The study
findings show that marketing training helps the sales representatives, in the
pharmaceutical industry, to implement ethical and relevant marketing techniques that
improve the commercialization of pharmaceutical products and services. Embedding
ethical considerations in marketing training should help to minimize unethical behavior
of sales representatives during professional practice. The functioning of pharmaceutical
companies is multidimensional comprising doctors as prescribers, organizations as payers
covering partial or complete costs of pharmaceutical products, and patients. These
dimensions call for ethical standards in providing efficient services and products and
limiting the effect of unethical behavior among sales representatives in the
pharmaceutical industry.
Marketing training in pharmaceutical companies aims at creating lasting
relationships between stakeholders and sales representatives. This training involves
pharmaceutical relationship marketing that embarks on sales representatives instituting,
maintaining, and enhancing relationships with consumers in support of social concerns
(Enyinda et al., 2018). The social aspect of ethical principles requires keen attention from
sales representatives in meeting their obligations with the public’s interests in mind.
Generating the right marketing mix involves marketing training that will provide efficient
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and ethical tools as instruments for meeting consumers’ satisfaction, motivating sales
representatives, and facilitating ethical decision-making.
Recommendations for Action
Pharmaceutical companies might use the findings of this study to develop
effective marketing training packages for their sales representatives. I recommend that
pharmaceutical companies allocate diverse resources towards achieving ethical marketing
training for their employees. I also recommend that every pharmaceutical company
should identify a set of ethical standards to inculcate in their business practices to achieve
universal benefits for their clientele and sales representatives. The pharmaceutical
industry should engage stakeholders to validate their ethics code of conduct and assess
gaps in the provision of ethical marketing training for their sales representatives and
medical practitioners. It is also important for businesses in this industry to perform
quality assurance checks in multiple departments to identify ethical needs in training
packages and employee behavior.
Training tools could adopt perspectives such as, eco-innovation and ecoorganization to improve corporate performance by enhancing employee job satisfaction
levels, reducing medical transaction and handling costs, sustaining important changes,
and reducing supply chain costs (Hassan & Daud, 2017; Qian et al., 2019). In addition, I
also advocate for improved relationships between stakeholders and pharmaceutical
companies. This could involve effective interactions comprising all-rounded
communication with stakeholders, physicians, and sales representatives. Participants’
awareness of ethical compliance, safeguarding, and safety is also recommended to
increase ethical behavior during clinical trials and overall medical practice (González-
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Saldivar et al., 2019). I also recommend that marketing training targeting pharmaceutical
companies embody ethics in incentivized programs to promote an ethical culture among
sales representatives. Organizational policies affecting pharmaceutical companies should
constitute ethical guidelines and practices to help professionals consequently align their
interactions and behavior (Gupta et al., 2016). Due to the increasing regulations in the
pharmaceutical industry, pharmaceutical companies should develop training programs
that help employees to increase their commitment and apply acquired knowledge in daily
practices.
Recommendations for Further Research
This study findings indicate some gaps in research. The need for new models of
organization and training on ethical behavior are relevant in marketing training for sales
representatives. There is inadequate research on eco-innovation and eco-organization and
how it impacts the actions and activities of pharmaceutical companies. This research
could help enlighten how these emerging constructs influence medical processes and
dimensions in the pharmaceutical industry. Furthermore, there is also limited evidence on
the perception of participants in clinical trials about ethical compliance protection, and
wellbeing. Research in this area could help to identify imperatives for ethical adherence
among participants in clinical trials and needs that the pharmaceutical companies can
fulfill. This study also identified the need to increase research on marketing training on
the angle of digital tools in pharma-marketing, medical education and strategy, as well as
sales function. The exponential application of digital tools in pharmaceutical marketing
could lead to engage more studies on the integration of ethics in digital marketing. Hence,
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research must also focus on how sales practitioners can be trained on ethical digital
marketing.
Future studies should also give attention to miscellaneous relations between
medical professionals and pharmaceutical industry. The involvement of sales
representatives in sustainable drug innovation and distribution are other areas that could
be investigated. Due to sales representatives’ role in many aspects, research should
incorporate diverse roles of sales representatives in developing sustainable medicine
supply and supply chain procedures involved. Research in this area should also address
ways to solve decline in discovery and approval of new medicines. Also, research on
marketing training embarking on marketing communications between sales
representatives and young adults and children is long overdue. Studies in this area could
help people understand how ethical marketing can be applied to ensure that children and
young adults receive appropriate marketing content for objective perceptions on various
medications.
Reflections
Challenging as it was, conducting a doctoral study had a positive impact on my
education. The process was engaging and I found fulfillment in reviewing and assessing
various scholarly materials to obtain required insights into strategies in marketing
training to reduce unethical behavior among sales representatives in the pharmaceutical
industry. The research process also provided a rare opportunity to engage diverse
knowledge bases and information related to my study. The study process also facilitated
the development of a work and study ethic by integrating planning, coordination, and
arrangement of study materials. My time during the doctoral study was fulfilling and I
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was intrigued by the level of detail offered in the research material I used in my study.
Upon reflection, I was also exposed to some time and resource constraints when
conducting the interviews and documenting findings. Thematic presentation of the
findings was also demanding and required an analytical review of both findings and
academia to make sense of the suppositions in this study.
During the research process, I found the importance of marketing training
strategies in mitigating unethical sales behavior among sales representatives to be
personally refreshing. I was fascinated by the lack of ethical standards in an industry that
handles directly ingested products. I also found it morally irresponsible that sales
representatives and medical practitioners could engage anything other than moral
precedence in servicing patients’ needs. In addition, I found it interesting that there are
new constructs to solving unethical behavior among sales representatives such as ecoinnovation and eco-organization. Besides, the urgency of ethical marketing training in
pharmaceutical companies was disappointing to discover based on past perspectives that
the industry maintained high standards of ethics. This however supports my use of openended questions in the interviewing process to discover what participants perceived of the
industry’s ethical standards. Completion of this doctoral study helped me to understand
the importance of adopting multiple perspectives on particular topical issues and listening
objectively.
Conclusion
The findings of this study bring to conclusion that developing ethical standards is
possible through communication, building relationships, and marketing and selling
products. Developing organizational policy targets corruption prevention, handling
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financial transactions, and regulating activities. Training and development programs
provide training on ethical business practice and standard operating procedures, and
building and sharpening skill set. The study found there is an alignment between the
findings and the general theory of marketing ethics. Ethical considerations were found to
be important in the medical professional practice. The study found ethics to be
indispensable aspect of modern pharmaceutical industry and to have a significant impact
on social change. Ethics helps in achieving sustainability in medicine discovery,
production, and distribution. The study recommends that pharmaceutical companies use
the findings in enhancing their marketing training packages to realize ethics for sales
representatives. There is also an urgent need to invest time and intellect towards
advancing knowledge in eco-organization and eco-innovation. Other areas of interest
include digital marketing training, evaluation of medical professionals’ relations with the
industry, and marketing techniques directed to young adults and children.
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Appendix A: Interview Protocol
Preparation for the interview. After having Walden University IRB approval, I
will email the IRB-approved participation invitation to the potential participants. This
invitation will contain information related to the back ground and the purpose of the
study. If the potential participants voluntarily agree to participate in the study, I will ask
them to provide their time availability (date and time) for the phone interview.
Informed consent. The informed consent form contains the objective of the
study, background information, research procedures, some interview question examples,
and my contact information. I will make sure the participants understand the study. And I
will answer any questions related to the study.
Before the interview. Before beginning the interview, I will make sure that I
received the signed informed consent from the interviewee (participant). Also, I will
ensure that the time is still convenient for the participants and they are ready for the
interview. Then, I will turn on the recorder and my phone to start recording the interview
(for transcription purposes) and I will mention the participant’s identifier number for the
analysis.
Beginning the interview. I will begin all phone interviews by thanking the
participants for their willingness to participate in this research. Then, I will introduce
myself, describe the study objectives, and explain the benefits (from business and social
perspectives) of conducting the research.
Conducting the interview. The interview will last for around 45 to 60 minutes. A
semistructured interview will contain open-ended interview questions (see Appendix B).
I will give the participant sufficient time to answer each question. If it is necessary, I will
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repeat participant’s answer to make sure that I understand, and I will ask probing and
follow up questions to have more information and clarification from the participants.
Theme verification. I will identify major themes discussed during the interview
and will ask participants to confirm.
Coding. I will assign a unique identifier to each participant to keep the privacy
and privacy of the participants and maintaining the confidentiality of the data. I will code
the first participant as P1, the second as P2, and will continue using the same numerical
coding for the all other participant in this study. Then, the next step will be to keep the
excel sheet that links the participant’s name and the unique identifier in a USB memory
stick locked with a password. No one will have this password except me. Also, I will
properly store the raw data in an encrypted file (that I will save on the USB memory
stick) to ensure the confidentiality of the data and maintain the privacy of the
participants. I will keep this USB memory stick in my home office cabinet for five years
as it requested by Walden University.
Ending the interview. After having the answers to all my questions, I will end all
interview by thanking the participants for their time. I will tell the participant that I will
email them a summary of the analyzed data (from the interview) so they can review (it
will take around 20 to 30 minutes of their time). And the participants respond (within 5 to
7 business days) after reviewing the summary. The participants can respond by (a)
confirming the accuracy, and/or (b) providing any inconsistencies, and/or (c) providing
additional information.
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Appendix B: Interview Questions
1. What training strategies do you use to improve marketing training to reduce
unethical sales representative behavior?
2. What framework(s) did you use to develop and implement your ethical marketing
training program?
3. How did you assess the effectiveness of your strategies for marketing training?
4. What were the key challenges to implementing your strategies for ethical
marketing training elements?
5. How did you overcome the key challenges in the implementation of ethical
marketing training elements?
6. What additional information would you like to share that we did not cover during
this interview about the strategies to improve marketing training used to reduce
unethical sales representative behavior?

